EP0933096B1 - Laser for dermal ablation - Google Patents

Laser for dermal ablation Download PDF

Info

Publication number
EP0933096B1
EP0933096B1 EP99300177A EP99300177A EP0933096B1 EP 0933096 B1 EP0933096 B1 EP 0933096B1 EP 99300177 A EP99300177 A EP 99300177A EP 99300177 A EP99300177 A EP 99300177A EP 0933096 B1 EP0933096 B1 EP 0933096B1
Authority
EP
European Patent Office
Prior art keywords
skin
laser
light source
locations
location
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP99300177A
Other languages
German (de)
French (fr)
Other versions
EP0933096A2 (en
EP0933096A3 (en
Inventor
James Jeffrey Wynne
Stephen Henry Gomory
Jerome Marvin Felsenstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Business Machines Corp
Original Assignee
International Business Machines Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Business Machines Corp filed Critical International Business Machines Corp
Publication of EP0933096A2 publication Critical patent/EP0933096A2/en
Publication of EP0933096A3 publication Critical patent/EP0933096A3/en
Application granted granted Critical
Publication of EP0933096B1 publication Critical patent/EP0933096B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/203Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37Surgical systems with images on a monitor during operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00057Light
    • A61B2017/00061Light spectrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00747Dermatology
    • A61B2017/00756Port wine stains
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452Skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00696Controlled or regulated parameters
    • A61B2018/00738Depth, e.g. depth of ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00904Automatic detection of target tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B2018/2035Beam shaping or redirecting; Optical components therefor
    • A61B2018/20351Scanning mechanisms
    • A61B2018/20357Scanning mechanisms by movable optical fibre end
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B2018/2035Beam shaping or redirecting; Optical components therefor
    • A61B2018/20351Scanning mechanisms
    • A61B2018/20359Scanning mechanisms by movable mirrors, e.g. galvanometric
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B2018/2065Multiwave; Wavelength mixing, e.g. using four or more wavelengths
    • A61B2018/207Multiwave; Wavelength mixing, e.g. using four or more wavelengths mixing two wavelengths
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/04Protection of tissue around surgical sites against effects of non-mechanical surgery, e.g. laser surgery
    • A61B2090/0409Specification of type of protection measures
    • A61B2090/0436Shielding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/04Protection of tissue around surgical sites against effects of non-mechanical surgery, e.g. laser surgery
    • A61B2090/049Protection of tissue around surgical sites against effects of non-mechanical surgery, e.g. laser surgery against light, e.g. laser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37Surgical systems with images on a monitor during operation
    • A61B2090/373Surgical systems with images on a monitor during operation using light, e.g. by using optical scanners

Definitions

  • Skin problems are pervasive in society. People suffer from conditions ranging from the cosmetic, such as benign discoloration, to fatal ailments, such as malignant melanomas. Treatments range from cosmetic "cover-up" makeup to surgical excision.
  • the removal (or "skin peel") of an outer layer of skin is used to treat conditions such as acne, age spots (superficial regions of excess melanin), shallow lesions (e.g. actinic keratoses), and aged skin.
  • Figure 1 depicts a cross section of normal human skin. The depth of the outer layer, or epidermis (105), varies, with ranges typically from 50-150 ⁇ m in thickness. The epidermis (105) is separated from the underlying corium (dermis) (110) by a germinative layer of columnar basal cells (120). The epidermal/dermal interface is characterized by undulations.
  • the basal cells (120) produce a continuing supply of keratinocytes, which are the microscopic components of the epidermis (105). Specialized cells called melanocytes (125), also reside in the basal cell (120) layer and produce the pigment melanin (130). Although some of the melanin (130) migrates toward the surface of the skin with the keratinocytes, the greatest concentration of melanin (130) remains in the basal cell layer (120).
  • the uppermost layer of the dermis (110), which is adjacent to the basal cell layer (120), is known as the papillary dermis, and the papillae range in width from 25-100 ⁇ m, separated by rete ridges ("valleys") of comparable width.
  • Removal of the epidermis (105) eliminates superficial sun damage, including keratoses, lentigenes, and fine wrinkling. Removal of the most superficial portions of the dermis (110), i.e. the uppermost papillary dermis, eliminates solar elastosis and ameliorates wrinkling, with little or no scarring.
  • CO 2 laser radiation in the 9 - 11 ⁇ m region of the infrared
  • water in all tissue
  • the radiation features that result in reduced collateral damage are: a wavelength that is strongly (optically) absorbed; and a pulse duration that is short compared to the time for deposited energy to diffuse into the surrounding tissue; (see e.g., R. J. Lane, J. J. Wynne, and R. G. Geronemus, "Ultraviolet Laser Ablation of Skin: Healing Studies and a Thermal Model", Lasers in Surgery and Medicine 6: 504-513 (1987 )).
  • the short pulse CO laser with an absorption coefficient in tissue of -1/50 ⁇ m -1 and a pulse duration of -10-100 ns, leads to a reduction of collateral damage as compared to a continuous wave (cw) CO 2 laser or lasers at other visible and near infrared wavelengths.
  • a newer treatment that is gaining in popularity uses a pulsed erbium YAG (Er:YAG) laser, emitting radiation at 2.94 ⁇ m in the infrared, where water absorption is even stronger than at CO 2 wavelengths.
  • Er:YAG light is approximately 10 times more strongly absorbed in skin than CO 2 laser light.
  • a shallower layer of skin absorbs the radiation and is vaporized and ablated from the surface, leaving a thinner thermally damaged and coagulated layer adjacent to the removed tissue. Damage has not been observed to exceed a depth of -50 ⁇ m of collagen denaturation.
  • Treatment with the Er:YAG laser rejuvenates skin, with less pain, less inflammation, and more rapid healing than treatment with the CO 2 laser.
  • the depth of penetration with the Er:YAG laser being shallower, does not thermally stimulate new collagen growth as much as the CO 2 laser, so fine wrinkles are not eradicated as effectively.
  • Dermatologists and cosmetic surgeons are finding the Er:YAG laser preferable for younger patients who have superficial skin damage but less wrinkling, while the CO 2 laser is thought to be preferable for older patients who want to have fine wrinkles removed around the lips and the eyes (see e.g., Betsy Bates, "Dermatologists Give Er:YAG Laser Mixed Reviews", Skin & Allergy News 28, No. 11 : 42 (Nov. 1997)).
  • the ablation depth and the depth of coagulated skin limits the precision with which the Er:YAG can remove epidermal tissue without damaging the underlying papillary dermis. And while pain is lessened, many patients still require some sort of anesthesia during treatment and the application of a topical antibiotic/antimicrobial agent following treatment to prevent infection during healing.
  • uv ultraviolet
  • the present invention is directed to a system (called a Dermablator) that can be used to carry out an improved "laser peel" of the skin.
  • the present invention is used in a process, Dermablation, that leads to clean, precise removal of surface skin while minimizing collateral damage to the skin underlying the treated region.
  • An example of a surgical system for removing skin having features of the present invention includes: a pulsed light source capable of delivering a fluence F exceeding an ablation threshold fluence F th ; and a control mechanism, coupled to the light source, for directing light from the light source to locations on the skin and determining if a skin location has been ablated to a desired depth.
  • the light source is a laser, for example: an argon fluoride (ArF) laser having a wavelength of approximately 193 nm.
  • ArF argon fluoride
  • the present invention has other features which limit the depth of ablation by utilizing feedback from the physiology of the skin, namely the infusion of blood into the area of excision when skin has been ablated to a sufficient depth to produce bleeding.
  • the infusion of blood can act as a "stop" to prevent further ablation, thereby effectively terminating the dermablation.
  • the blood can then be removed by washing it away with physiological saline solution, clearing the area for further treatment.
  • the system of the present invention utilizes a laser having a relatively low blood absorption characteristic, such as an ArF laser, to ablate the skin to a sufficient depth to produce bleeding.
  • a second laser such as a uv light source with a different wavelength and a relatively high blood absorption characteristic, is then utilized to penetrate the blood, heating it sufficiently to coagulate the blood, stemming subsequent bleeding, yet leaving the tissue with an intact ability to heal without the formation of scar tissue.
  • the system further comprises: a coagulating light source having a different wavelength than the ArF laser and a relatively high blood absorption characteristic; means for detecting the appearance of blood at a given skin location; and means for switching to the coagulating light source, in response to the detection of blood at a given skin location.
  • Examples of the coagulating light source include a krypton fluoride (KrF) laser having a wavelength of approximately 248 nm; a xenon chloride (XeCl) laser having a wavelength of approximately 308 nm; and a xenon fluoride (XeF) laser having a wavelength of approximately 351 nm.
  • KrF krypton fluoride
  • XeCl xenon chloride
  • XeF xenon fluoride
  • the present invention has still other features which provide precise lateral and depth control, permitting the epidermis to be removed down to the papillary dermis, following the undulations of the papillary dermis, so that the papillae are not penetrated even though the epidermis is removed in the adjacent rete ridges.
  • This lateral and depth control may be accomplished by using careful observation, assisted by spectroscopic detection, to identify when the epidermis has been removed, exposing the underlying dermis, with spatial resolution appropriate for the spacing of the undulations of the papillary dermis.
  • the lateral and depth control of the present invention is one advantage over prior art laser peels operating at wavelengths which lead to thermal damage in the tissue underlying the ablated region that renders this underlying tissue denatured and coagulated.
  • the use of current CO 2 lasers make it difficult if not impossible to determine how deep the ablation has penetrated based on real-time observation and/or feedback control.
  • the present invention has yet other features which provide a feedback control mechanism which utilizes the optical characteristics such as the colour, appearance and remittance of the definable skin layers.
  • a feedback control mechanism which utilizes the optical characteristics such as the colour, appearance and remittance of the definable skin layers.
  • the control mechanism could be a feedback control mechanism, comprising: a second light source illuminating the skin; and at least one photodetector having an input and an output; the input receiving scattered/reflected/fluoresced light from the second light source, and the output providing a feedback signal to the system causing the light source to be inhibited at a given location, in response to the second light source at the input.
  • the second light source include a visible light source; an infrared light source; and an ambient light source.
  • Another example of the second light source is one which is both relatively highly absorbed by epidermal melanin and relatively highly remitted by a dermal layer.
  • the present invention has features that serve to automate the removal of skin, wherein the ablating laser beam can be scanned accurately and repeatably over a designated area of skin under the control of a computer system which utilizes real-time observation and/or feedback to control the depth of ablation at each location.
  • the areas to be scanned may be designated by an adjunct visible alignment laser, employing an input device to scan the alignment beam over the area of skin to be treated and recording the beam positions for subsequent automatic scan of the ablating laser beam over the same scan domain.
  • the area of treatment may be specified by recording its image with a camera and designating on the digital image the locations to be treated.
  • An example of an automated system having features of the present invention includes an alignment and recording mechanism, comprising: a visible laser emitting a beam illuminating the skin at a location coincident with the ablating light; means for scanning the beam across the locations on the skin; and means for recording scanned beam positions, coupled to the means for scanning, for subsequent automatic scan of an ablating light source across the locations on the skin.
  • An example of the computer and control mechanism includes: one or more rotatable mirrors, the mirrors positioned in the light source path for controllably scanning the light source; one or more motors, coupled to the mirrors, for angularly rotating and feeding back angular positions of the one or more mirrors; and a computer, coupled to the light source and the motors for controlling the motors and selectively shuttering the light source at a given location on the skin.
  • the computer includes a feedback control system, coupled to the light source for selectively shuttering the light source at a given location on the skin.
  • the shuttering mechanism could be an active mask array, coupled to the feedback control system, for selectively shuttering the light source at a given location that has been ablated to the desired depth.
  • Still another example of the present invention is a robot/laser system, further including a camera for visualizing an image of the locations on the skin; a computer, coupled to the camera, the computer having an output for displaying and an input for designating the locations of the skin to which the laser is directed.
  • the robot/laser system further includes: one or more rotatable mirrors, the mirrors positioned in the light source path for controllably scanning the light source; one or more motors, coupled to the mirrors, for angularly rotating and feeding back angular positions of the one or more mirrors; a second light source illuminating the skin being ablated, wherein light from the second light source is scattered/reflected/fluoresced from the ablated location; a photodetector having an input and an output; the input for receiving the light from the second light source; and the output coupled to the system and providing a feedback signal to the system for inhibiting the pulsed light source at a given location.
  • the robot/laser system includes a registration mechanism for relating coordinates of a point in one patient coordinate frame of reference to a corresponding position in the robot/laser frame of reference.
  • An example of the registration mechanism includes means for attaching fiducials to the skin; a movable tracking laser, coupled to the computer, for recording 3D coordinates of the fiducials; and triangulation means, for establishing 3D locations of the fiducials in the tracking laser frame of reference.
  • Another example of the registration mechanism comprises: means for relating points corresponding to an area of skin in the patient frame of reference subsequent to a change in position, to the same area of skin in a patient frame of reference prior to said change in position.
  • Yet another example of the registration mechanism comprises means for accurately directing the light source by relating points on an area of skin defined in a digital image, to an area of skin on the patient.
  • An alternative registration mechanism comprises: means for attaching fiducials to the skin; a pair of cameras, coupled to the computer and mounted at fixed positions relative to the robot/laser system for recording coordinates of the fiducials; calibration means for relating the fixed positions of the cameras to the robot/laser system from a predetermined calibration transformation; and a camera model for mapping the relationship between each location in 2D camera images and a set of 3D points in an imaged space that map to it.
  • a robot/laser system of the present invention includes: a camera for visualizing an image of the locations on the skin; a computer, coupled to the camera, the computer having an output for displaying and an input for designating the locations of the skin to which the laser is directed; a flexible optical fibre bundle having an output end and an input end, the output end being attached to a mask for affixing to the patient and the input end adapted for receiving the light source in a predetermined manner; and a removable mirror located adjacent to the input end for viewing the skin through the fibre bundle using the camera.
  • the Dermablator/Dermablation can provide a modality to treat other pathologies of the epidermis, including Bowen s disease, exophytic warts, flat warts, lichen-planus-like keratosis (LPLK), and actinic keratoses.
  • this invention provides an apparatus and process for treating a wide range of common skin conditions.
  • An additional application is to use Dermablation to remove a basal cell carcinoma.
  • the lesion can be selectively marked with an exogenous agent that provides contrast between the lesion and surrounding healthy tissue.
  • Basal cell carcinomas are differentiated from surrounding tissue in biopsy specimens by standard histological treatment, i.e., staining the tissue with chemicals. Such histology is used to make the diagnosis of basal cell carcinoma in the biopsy.
  • Staining agents can be applied directly on the patient, providing a visible differentiation of the basal cell carcinoma, such differentiation being used to guide the Dermablator to remove the lesion with minimal collateral damage.
  • the system of the present invention is used in a method for removing skin comprising the steps of:
  • controllably determining step comprises the step of controllably ablating the epidermis along the contours of an epidermal/dermal boundary.
  • controllably determining step further comprises the step of detecting a colour change near or at the epidermal/dermal boundary.
  • a method of use of the device of the present invention further comprises the steps of: controllably scanning the light source across the skin; and selectively shuttering the light source at a given location on the skin when it has been ablated to the desired depth.
  • a method of use of the device of the present invention further comprises the steps of: illuminating the skin with a beam from a visible laser at a location coincident with the ablating light; scanning the beam across the locations on the skin; recording scanned beam positions, in response to said scanning step; and automatically scanning of an ablating light source across the locations on the skin, in response to said recording step.
  • UV light removes thin layers of tissue at a rate that depends on the fluence F of the light.
  • F th There is a threshold fluence F th , and areas at the surface of the tissue that are irradiated with a F exceeding F th are ablated to a depth of approximately 1 ⁇ m for each (short) pulse of light.
  • the unablated tissue underlying and adjacent to the ablated area absorbs some light and is damaged to a depth of somewhat less than 1 ⁇ m, essentially to sub-cellular depth.
  • Successive light pulses remove additional thin, layers, and after the last pulse there is only an ultra-thin, sub-cellular layer of tissue at the margins of the ablated region that experiences damage. Thus, collateral damage is intrinsically minimized.
  • the surgeon or medical practitioner needs a source of light delivering F > F th and a delivery tool.
  • the source might be a far UV pulsed laser, such as an excimer laser.
  • Different excimer lasers emit radiation at different wavelengths, which ablate tissue to different depths and with different F th .
  • Well-known far uv excimer laser systems include XeF at 351 nm, XeCl at 308 nm, KrF at 248 nm, and ArF at 193 nm. All excimer laser systems have been shown to be capable of emitting pulses of far uv light that exceed ablation threshold for human (and animal) tissue, including skin.
  • Figure 2 depicts an example of an apparatus having features of the present invention.
  • the delivery tool might be a "pipe" 205 through which the light beam 210 is transmitted from source to tissue, with an adjustable steering mirror 215 to direct the beam around corners and an adjustable lens/masking system, such as lens 220 and slit 225 at the delivery end, to shape the light beam into the desired pattern where it irradiates the tissue.
  • an adjustable steering mirror 215 to direct the beam around corners
  • an adjustable lens/masking system such as lens 220 and slit 225 at the delivery end, to shape the light beam into the desired pattern where it irradiates the tissue.
  • Figure 3 depicts another example of an apparatus having features of the present invention.
  • the delivery tool might be an optical fibre, or a fibre bundle 305 terminated by a hand-held tool 310 that the physician or technician can manipulate to deliver the light beam to the skin area to be irradiated.
  • the delivery tool of Fig. 2 can be adjusted to focus the uv irradiation beam to an area small in comparison to the cross-sectional area of a rete ridge of the epidermis. Then the beam can irradiate the area until the epidermis is completely removed, before the beam is scanned/displaced to an adjacent area where the procedure is repeated, ablating this new area of epidermis down to the dermis. In this way the contours of the irregular epidermal/dermal interface can be taken into account. By scanning the uv laser beam across an area of skin in this manner, only epidermis will be removed, with depth precision that mirrors the contours of the papillae of the papillary dermis.
  • one aspect of the present invention employs a unique detection scheme to enable a precisely contoured removal of tissue.
  • the epidermis has melanin and thereby is coloured, whereas the dermis is white.
  • the medical practitioner can watch the ablated site for the appearance of white dermal tissue.
  • the skin to be irradiated 405 can also be defined by covering the area with a masking material that blocks/absorbs/reflects radiation except at the desired location for the tissue ablation.
  • the masking material 410 could even be made of an erodable material and fabricated with variable thickness, so that a homogenous light beam erodes away the material and ablates skin under the mask only after it has eroded entirely through the mask.
  • different areas of tissue would receive different "doses" of radiation, producing areas of treated skin with the depth of the ablation controlled by the careful fabrication of the erodable mask.
  • the mask could be impregnated with a marker material, e.g., a fluorescent dye, that would give a clearly recognizable signal when the mask was being eroded, such signal ceasing as soon as the mask was entirely eroded through.
  • a marker material e.g., a fluorescent dye
  • the "masking” could be accomplished by applying a "sunscreen” cream or ointment, e.g. zinc oxide, to cover areas where tissue ablation is not wanted. This sunscreen would have to be of sufficient thickness so that it is not completely eroded through to the underlying skin during the treatment.
  • a robot/laser system can serve to scan an ablating laser beam to deliver a precisely controlled number of pulses to each location on the area of skin being irradiated.
  • Figure 4B depicts an example of such a robot/laser system having features of the present invention.
  • the analogy is to a raster scan of an electron beam in a cathode ray tube (TV) display.
  • the amount of energy, or number of pulses, delivered during one scan (or pass) of the laser beam is small enough so that an appropriate dose can be applied to each location by varying the number of times the area is scanned.
  • one could initially deliver a larger amount of energy per scan sacrificing precision of depth control, and getting close to the desired depth.
  • successive scans could be carried out at progressively less laser energy, providing increased precision of depth control and allowing the surgeon the fine control to zero in on the desired depth of tissue removal.
  • one scan could consist of one laser pulse for each location of irradiated tissue or many pulses for each location, the number of pulses being selected to remove tissue to a desired depth.
  • a stationary laser 415 emitting a beam that is guided by a computer-controlled mechanism.
  • one such mechanism could be a pair of mirrors 420 rotating on axes at right angles to one another.
  • the mirrors could be controlled by motors (not shown) having position encoders that enable precise, digital designation of the mirror angles of rotation 430.
  • the motors can be controlled through a standard A/D, D/A circuitry interfaced with a computer 425 running standard servo-control software.
  • the motor encoder information provides the necessary positioning information for fine control.
  • This system is preferably engineered to be capable of accurate positioning of the laser beam on the skin to within 25 ⁇ m at a typical target distance of 0.5 m.
  • the control scheme, encoders, motors, mechanical accuracy, and distance from target all affect the overall precision. We assume that the robot has been calibrated, and the forward and inverse kinematics are known with sufficient precision to meet these accuracy requirements.
  • the system (examples of which are described below) is preferably capable of positioning the laser beam with the required precision at any location on the (irregular) surface of the skin.
  • the surgeon can set the area scanned by the laser by using several possible techniques. For example, the surgeon can affix a physical mask or plate on the robot/laser system that restricts the range of mirror angles for which the beam escapes the laser device. Alternatively, the surgeon could set the extent of the range of the mirror angles by interacting with the controller software through a user input device such as a keyboard, mouse, or joystick. Once the surgeon has fixed the scan area, he can verify that it is what he intended by instructing the laser system to scan using visible light. This allows the surgeon to preview the region to be scanned by the laser. If the scanned area is not appropriate, the surgeon can reposition the patient or adjust the range of the laser as described above.
  • the system can illuminate the area to be treated with light visible to the human eye or to an electronic detector or imaging detector array. This visible light serves to align the system by illuminating the tissue at the same location where the ablating uv beam strikes the tissue, when the uv is not otherwise shuttered or turned off.
  • the system can be a two degrees of freedom (2DOF) robotic device that can accurately and repeatably scan a laser beam over a designated area of skin.
  • the system could be a 2DOF robotic arm with a laser beam emerging from the delivery end.
  • the robot/laser system can be programmed to: (i) systematically visit every location within a designated area in succession (full raster scan); (ii) visit only certain locations of interest on the skin surface; or (iii) perform a full raster scan with the exclusion of certain designated regions within the full area being scanned.
  • the general procedure is to alternate between (a) designating regions of tissue to be irradiated and (b) exposing these regions of interest to laser energy, thereby removing a thin layer of tissue, with steps (a) and (b) being repeated until the treatment is complete.
  • the robot/laser system 400 is capable of emitting two different laser beams, a uv radiation laser for ablation and a visible laser for alignment. With the uv radiation laser source shuttered, the surgeon scans the visible alignment beam 412 across the area of skin to be treated, thereby designating the area for the system control mechanism. The surgeon then applies a physical mask or masking material 410 to those regions 406 within the area that will be illuminated during the ablation scan but which are not to receive treatment, i.e. not to be ablated.
  • the mask might be made of a reflective material, thereby directing the uv laser energy away from the underlying skin.
  • it could be made of an absorbing material with a threshold for ablation greater than that of skin.
  • the absorbing material might be of sufficient thickness that the process does not erode all the way through the mask.
  • FIG. 4C depicts an example of a computer-controlled robot/laser system 402 in accordance with the present invention capable of emitting two different laser beams: a uv radiation laser for ablation; and a visible laser for alignment.
  • the surgeon can, as before, designate the locations to be ablated by using an alignment light 412 to define these locations.
  • the alignment light can be pointed and moved to outline the locations of skin to be treated.
  • a phosphorescent material can be applied to make the outlined region easier to read.
  • An input device 450 such as a joystick, mouse, or force-torque sensor, can be used to translate the surgeon's hand motion into motion commands for servo motors controlling the visible beam position. It is well known in the art of computer-integrated surgery to record in a computer the specific point locations on or in a patient using a multitude or variety of 3D localizing technologies, e.g., mechanical pointing devices. See e.g., Computer-integrated Surgery: Technology and Clinical Applications, Russell H. Taylor et al., (editors), The MIT Press, pp. 5-19,(1996 ) (hereinafter "Computer Surgery").
  • a robot/laser system preferably includes computer software for recording the visible beam positions which have been designated by the surgeon for subsequent "playback" using the ablating laser.
  • the surgeon outlines the locations to be ablated directly on the patient's skin by using the visible light beam as a "drawing" tool.
  • a complete procedure may involve many iterations.
  • the surgeon can use the visible light 412 to position the system.
  • the area of interest 455 can then be outlined. At this point, these locations can be previewed in visible light or the system switched to ablation mode and directed to deliver controlled treatment of these locations.
  • the patient should not move from the time the surgeon designates the locations of interest to the time the ablation scan is completed. The patient is then free to move.
  • new areas of interest can be designated, which may or may not overlap the previous locations, and the process repeated. This procedure is repeated for as many times as it takes to ablate all of the designated locations of skin to the desired depths. The surgeon is typically making decisions from iteration to iteration.
  • the area being treated can require many iterations to attain the full treatment and if the patient moves between iterations, the treatment region must be re-designated by the surgeon. This may become tedious, slow and lead to inaccurate treatment.
  • it is desirable to develop a registration, well known in the art, between the area of treatment on the patient and the coordinate frame of the robot see e.g., Computer Surgery, pp. 75-97 ).
  • a more detailed example of a registration technique in accordance with the present invention follows in scenario (iii), but briefly, the region can be registered to the patient by determining the three-dimensional (3D) position of the area of skin surface to be treated. This surface area is then tracked when the patient moves.
  • a location of treatment designated by the surgeon can be identified by the system, from iteration to iteration, even though the patient moves, without active re-designation by the surgeon.
  • This same capability allows the surgeon to build up a complicated pattern of treatment over successive iterations. For example, the surgeon can re-irradiate a region of locations previously irradiated with the additional specification of a region within the larger region that will be "electronically masked off".
  • FIG. 5 depicts an example of a computer assisted UV Dermablator system having features of the present invention.
  • a surgeon can designate locations of interest on a digital image 500 of a patient 505 on a computer display 510, rather than directly on the patient. This will make the region-editing functions easier to use.
  • a camera 515 can be mounted on the system such that the area of skin to be treated is within its field of view.
  • the system is preferably configured so that a digital image is available to a computer 525 for display, image processing, and interaction. To maintain a correspondence between the area designated in the camera image 500 and the area that will be scanned 530 by the ablating laser 550, these two areas must be registered with respect to one another. (Registration is described below).
  • the surgeon can use a visible alignment light to illuminate the patient and carry out a scan in order to get an appropriate initial placement of the system relative to the patient.
  • the surgeon then records ("snaps") an image of the patient.
  • an automatic (or semiautomatic) registration can be performed to align the laser system with the camera image.
  • the patient must not move until a scan with the ablating uv laser is complete.
  • the surgeon designates on the digital image the locations to be treated.
  • Working with this digital image makes available the full graphics power of the computer to provide a richer pallet of editing techniques, such as area growing, area shrinking, inversion, outlining, colour discrimination, etc.
  • the surgeon can then treat the designated locations using the ablating laser.
  • the patient may then move.
  • the process is then repeated for additional iterations (snap image, register, designate locations, ablate) until the surgeon determines that treatment is complete.
  • Scenarios (ii) and (iii) can call for some sort of registration to relate the coordinates of a point in one coordinate frame of reference to its corresponding position in a different coordinate frame of reference.
  • the points corresponding to an area of skin on the patient may need to be related to the area of skin defined earlier (before the patient moved).
  • an area of skin defined in a digital image must to be related to an area of skin on the patient, so that the ablating laser beam can be accurately aimed.
  • Such registration can be accomplished by attaching several markers, or fiducials 610, to the patient, pointing the tracking laser beam 607 at each fiducial while the tracking laser is in one mounting position, moving the tracking laser to a second mounting position, and repeating the pointing process, thereby establishing the 3D locations of each fiducial in R through triangulation.
  • markers or fiducials 610
  • the use of robot-assisted surgery and in particular fiducial markers for registration is well known in the art. See e.g., Kazanzides, et al, "An Integrated System for Cementless Hip Replacement," IEEE Engineering in Medicine and Biology Magazine 14, pp. 307-313 (1995 ).
  • the patient coordinate frame P is defined in terms of the fiducials 610.
  • This reference frame P is an orthonormal basis made up of the vectors x, y and z .
  • the x-axis of the patient coordinate frame P might be a vector formed by a line from a first fiducial f 1 to a second fiducial f, with f 1 serving as the origin of frame P. Additional fiducials might be placed at locations f 3 and f 4 .
  • Gram -Schmidt orthogonalization may be used to define y and z in terms of x and the coordinates of the fiducials 610 (in R).
  • the area of interest in the patient frame of reference is defined by constructing a surface 620 passing through the fiducials (the "fiducial surface").
  • this beam will intersect the fiducial surface 620 at a set of locations 625.
  • the set of 3D points corresponding to these intersections is fixed in the patient coordinate frame P, even when the patient moves. So, to register an area of interest after the patient moves, only the transformation R T P for the new position of the fiducials need be computed. Registration in scenario (iii) with a camera recording digital images of the patient has many similarities to scenario (ii).
  • the area of interest is defined in terms of the patient coordinate frame P by the intersection of the alignment laser and a surface 620 constructed through the known fiducial positions 610 and the locations of intersection 625.
  • the main difference is that the positions of the fiducials is determined by triangulation using two cameras 630 instead of using two different positions of a tracking laser.
  • the cameras can be mounted at fixed positions relative to the robot/laser frame 660. Their position (the measurement frame "M") relative to the robot/laser frame 660 is known from a calibration transformation M T R determined prior to the medical procedure and does not change in the course of this procedure.
  • M T R the calibration transformation
  • An accurate camera model has preferably also been built prior to the procedure, so that the relationship is known between each location (pixel) in the 2D camera image and the set of 3D points (within a cone) that map to it. Given this camera model, when the surgeon snaps the images, a pair of stereo images is captured and made accessible to a computer (not shown). Well known image processing techniques can be used to identify the fiducials 610 and to establish the coordinate axes ( x,y,z ) of the patient frame of reference P.
  • Ambiguity in establishing the correspondence between fiducial images in the pair of camera images may be resolved by the surgeon based on his visual observation of the patient. (See e.g., D. H. Ballard and C. M. Brown, Computer Vision (Prentice-Hall, Englewood Cliffs, NJ, 1982), pp. 88-93 ).
  • the surgeon can then designate an area of interest directly on one of the images on a computer screen, as described above.
  • the system translates this designation into the area of interest in the patient frame P.
  • the system is then capable of following this surgical plan, i.e. determining the set of robot/laser ablation locations that correspond to the region designated on the screen.
  • Alternative means to using the cameras 630 for locating the fiducials 610 include the use of a 3D digitizer 640 (an array of cameras that optically tracks light-emitting diode markers affixed to the patient), e.g., an OPTOTRAK TM device (manufactured by Northern Digital, Inc., Canada) (see. e.g. R. H. Taylor et al, "An overview of computer-integrated surgery at the IBM Thomas J. Watson Research Centre", IBM J Research and Development 40 , p.
  • a 3D digitizer 640 an array of cameras that optically tracks light-emitting diode markers affixed to the patient
  • OPTOTRAK TM device manufactured by Northern Digital, Inc., Canada
  • a calibrated pointing device 650 a mechanically manipulated pointer to reach out and point to the fiducials 610
  • a calibrated pointing device 650 a mechanically manipulated pointer to reach out and point to the fiducials 610
  • VIEWING WAND TM manufactured by ISG Technologies, Inc., Canada
  • UV Dermablator The surgeon makes the decision as to which area of skin to treat and how many pulses of light are to fall on each location of tissue. He can then set the robot/laser system on "automatic pilot”. But the surgeon will be watching the procedure and can intervene at any time, taking "manual" control of the system. This is analogous to putting an automobile in cruise control once a cruising speed is selected, but having the ability to instantly take back control by touching the brake pedal.
  • each location of skin being irradiated can be labelled and its history recorded by the computer. Then, with a safety threshold set in advance, the system will not deliver pulses in excess of that threshold without an explicit command by the surgeon.
  • Figure 7 depicts an example of an alternative system in accordance with the present invention for delivering laser energy to the patient's skin while permitting the patient to move throughout the procedure.
  • the system includes an optical fibre bundle 710, one end of which is clamped to a mask 715 worn by the patient while the other end, the input end 720, is scanned by an ablating laser beam 725 in a predetermined manner.
  • the fibre bundle 710 is preferably flexible and abuts the patient's skin.
  • the surgeon can look at the skin through the input end 720 of the fibre bundle 710, using, for example, a mirror 730 that snaps into position for viewing. This mirror 730 snaps out of the way for ablation, working like the mirror in a single lens reflex (SLR) camera.
  • SLR single lens reflex
  • a camera 735 can view the patients skin, deliver its image 750 to a computer 740 and computer display 745, and the surgeon can mark the areas to be treated as described in scenario (iii).
  • the ablation can proceed, the laser 700 scanning across the input end 720 of the fibre 710 in a predetermined pattern. Successive viewing, marking, and ablation iterations are carried out until the procedure is completed to the surgeon's satisfaction.
  • Use of this fibre bundle 710 eliminates the need for re-registration between each iteration, because the output end of the bundle does not move relative to the patient during the procedure.
  • the ablation of skin by pulsed uv light in accordance with the present invention can remove epidermal tissue with minimal damage to the underlying dermis and minimal scar tissue and erythema. Since each pulse of uv light removes less than a cellular layer of tissue, it is possible to control the procedure with great precision, ablating the skin to the desired depth and no more .
  • the skin is ablated to a depth where bleeding just commences, with no deeper penetration. So a process is needed to stop the ablation as soon as bleeding is detected. Alternatively, the process can be slowed at the first hint of bleeding and brought to a complete halt at an additional, adjustable predetermined depth, depending on the patient's skin condition.
  • the dermis which is much thicker than the epidermis (up to 4 mm thick), has fewer cells, and is mostly connective tissue or fibres. Blood vessels course through the dermis. The skin is vastly perfused with blood. The mean blood flow is many times greater than the minimum flow necessary for skin cell nutrition because cutaneous blood flow serves as a heat regulator of the entire organism. Thus blood is plentiful and flowing at depths just below the basement membrane. Once the ablation process perforates a capillary wall, blood will perfuse into the incision.
  • the aqueous chlorine ions in blood are a strong absorber of uv radiation at wavelengths below 200 nm, with an absorption maximum at 190 nm. This absorption differs from the absorption of uv light by cells and protein molecules in that the absorbed energy is not quickly degraded into heat. So the "salt water” that is the major component of blood will "block” the incoming uv light and attenuate or completely halt the ablation process, depending on how much blood is pooled in the cavity of the incision (The uv photon energy detaches an electron from the chlorine ion, leaving a chlorine atom and a solvated electron dissolved in the water.
  • One way to take advantage of this effect is to horizontally orient the skin surface being treated, and direct uv radiation in the spectral region of the photodetachment energy, e.g., an ArF laser radiation at 193 nm, at the target surface from above.
  • the photodetachment energy e.g., an ArF laser radiation at 193 nm
  • the patient can sit in a comfortable position and the punctate blood spots that appear when capillary walls are penetrated will serve to block further ablation of tissue under the punctate blood. Since the skin being treated varies in thickness, different regions of the skin will start to bleed at different depths of penetration, but the naturally occurring bleeding will block ablation at an appropriate depth for each region of skin.
  • Blood can be washed away with physiologic saline solution, but such solution will continue to act as a block against further ablation by uv radiation in the photodetachment energy spectral region, e.g., the ArF excimer laser at 193 nm.
  • the bleeding area can also be washed by deionized water, which is transparent to radiation at the uv wavelengths of the ArF, KrF, XeCl, and XeF excimer lasers.
  • Figure 8 depicts a dual laser system having features of the present invention.
  • first 193 nm radiation from an ArF laser 810 can be used to ablate the skin 815 until bleeding blocks the ablation.
  • the wavelength is changed (by, for example, using a second laser 820 supplied with a gas mixture producing longer wavelength light, such as KrF, XeCl or XeF) so that the radiation at the second wavelength will not be blocked by photodetachment, but will be absorbed by blood protein, heating it sufficiently to coagulate the blood.
  • a gas mixture producing longer wavelength light such as KrF, XeCl or XeF
  • Figure 9 depicts another example of a system not in accordance with the present invention.
  • evidence of bleeding can be detected using a visible illuminating laser 910 that is aimed at the skin to overlap the uv radiation 955, this visible beam 915 scattering from the rough surface of the skin being treated to form a visible "spot" that can be detected by the practitioner's eye or by a photodetector 930 mounted near the tissue being treated.
  • a small fraction of the visible laser beam will reflect specularly from the surface of the liquid and a major fraction of the visible laser beam (915) will be absorbed by the pigment (hemoglobin) in the red blood cells in the blood, leading to a great reduction of the light hitting the photodetector.
  • This reduction in signal can be fed back to the uv laser 950 power supply or to a beam shutter by a control signal 960 which terminates the surgical procedure.
  • the complete ablation of the epidermis can be detected by monitoring for the first appearance of the white dermal boundary 925.
  • the dermis is first revealed when the pigmented epidermis and basal cells are totally removed.
  • a focused laser beam 955 of small cross section compared to the area of a papillae or rete ridge
  • Such colour change can be detected visually by the medical practitioner's eye.
  • the colour change can be detected by the photodetector 930 monitoring the amount of scattered light from the visible laser beam 915.
  • the photodetector 930 might be equipped with a filter tuned to the colour of the illuminating visible laser beam 915.
  • the detection scheme discriminates against ambient light at all other colours, thereby improving the precision with which the appearance of the dermal boundary can be detected and used for feedback to terminate the surgical procedure.
  • Figure 10 depicts another example of a laser system having features of the present invention.
  • a laser system 1010 can apply a laser beam 1050 over a relatively large area, encompassing many papillary contours.
  • An active mask 1060 between the source 1010 of the beam and the skin, can be used to shutter selected areas of the beam (Fig. 10).
  • the mask 1060 could be controlled by a detector 1070 or an array of detectors, so that each area of the skin being irradiated can provide a colour-change based feedback signal 1075 to a control system 1080 which then inhibits or shutters a section of the laser beam irradiating that area, in a one-to-one "map".
  • the epidermis 1005 contains melanin while the dermal layer 1020 is white.
  • This mask could be controlled electro-optically, or even be mechanically shuttered by an array of opaque flaps that rotate into the beam so as to block selected areas.
  • the mask 1060 might be placed in the ablating laser beam 1050 at a location where the beam is relatively defocused, covering a large area. At such a location the laser beam 1050 will be of such low intensity and low fluence so as not to damage the mask. At this location, each element of the array can be relatively large. When the beam is focused by projection lenses 1065 to a smaller area 1090 on the skin, the light passing through each element will be correspondingly demagnified as well as intensified.
  • the pattern of light transmitted by the mask array may be projected to a correspondingly smaller area on the skin, yielding a transverse precision suitable for following the contours of the epidermal/dermal boundary.
  • the focusing increases the fluence of the laser beam, ensuring that it is above threshold for ablation.
  • the epidermis 1005 can be controllably ablated right down to the dermal boundary with great depth precision and transverse control, despite the irregular contours of the dermal/epidermal interface 1015.
  • the photodetector 1070 could be used in conjunction with and responsive to an illuminating laser 910, as depicted in Figure 9.
  • the skin can be modeled macroscopically as a multilayered optical system (see The Science of Photomedicine, edited by James Regan and John Parrish, Plenum Press, NY, (1982), Chapter 6, pp. 147-194 ).
  • the relation between sunburn protection and the degree of melanin pigmentation in the skin is well known. This is because melanin, which is present in the epidermis and is most concentrated in the basement membrane, is a strong absorber of both shorter wavelength visible light and UV radiation.
  • the epidermis can be modeled generally as an optically absorbing element while the underlying dermis acts as a diffuse reflector whose remittance increases with the wavelength.
  • the epidermal remittance in this region is essentially due to the regular reflectance at the surface of the skin (-5% for a normally incident beam).
  • a change (as detected by photodetector(s) (930, 1070)) in the remittance of an external (UV, visible or infrared) illuminating laser, resulting from the complete removal of the melanin-containing epidermis, could be fed back to selectively shutter the UV laser or the active mask 1060.
  • the illuminating laser might be scanned across the area being ablated through the mask array 1060, illuminating in sequence each area corresponding to the projected image of one of the elements of the mask array.
  • Scattered light detected by photodetector 1070 could then provide the feedback signal 1075 to shutter the laser beam selectively at the locations of the mask array that project to the areas of skin that have been ablated to the desired depth.
  • the photodetector would be selected to transmit its control signal in response to an increase (or decrease) in remittance for the wavelength of an illuminating laser emitting light in one of these spectral regions.
  • Melanin which is the pigment that colours the epidermis, originates from melanocytes in the basal cell layer. Once the basal layer is removed, a new basal layer must be regenerated in order to provide pigment to the overlying epidermis. If the skin is removed to such a depth that the hair follicles included in the region of removal are too badly damaged, they will fail to act as "seeds" for regeneration of a pigmented basal layer, and the healed region will appear to be much whiter (contain less melanin) than the surrounding skin.
  • the UV Dermablation method and apparatus of the present invention advantageously provides such fine depth control that the hair follicles will be spared from destruction, remaining viable and capable of acting as a source for regeneration of a fully functional basal layer, including fresh melanocytes capable of providing a pigmentation that matches the surrounding skin.
  • the skin to be treated can be first stained by an exogenous agent, a chemical such as those used for histological preparation of biopsy specimens. This will "mark" the lesion with a coloration and darkness that will provide contrast to surrounding healthy tissue. Then the scheme of Fig. 9 can be used to control the dermablation process, with a visible laser beam illuminating the tissue at the point of ablation, the scattered visible light being measured to determine if that point has lesion tissue or healthy tissue at the surface, and this measurement being used to control the shuttering of the uv beam when healthy tissue is at the point of irradiation. A scan can be taken over a designated area containing the basal cell carcinoma, and this scan can be repeated for a sufficient number of iterations until the lesion is entirely removed, as determined by the measurement signal derived from the scattered visible light.
  • an exogenous agent a chemical such as those used for histological preparation of biopsy specimens. This will "mark" the lesion with a coloration and darkness that will provide contrast to surrounding healthy tissue.

Description

    Background
  • Skin problems are pervasive in society. People suffer from conditions ranging from the cosmetic, such as benign discoloration, to fatal ailments, such as malignant melanomas. Treatments range from cosmetic "cover-up" makeup to surgical excision.
  • In particular, the removal (or "skin peel") of an outer layer of skin is used to treat conditions such as acne, age spots (superficial regions of excess melanin), shallow lesions (e.g. actinic keratoses), and aged skin. Figure 1 depicts a cross section of normal human skin. The depth of the outer layer, or epidermis (105), varies, with ranges typically from 50-150 µm in thickness. The epidermis (105) is separated from the underlying corium (dermis) (110) by a germinative layer of columnar basal cells (120). The epidermal/dermal interface is characterized by undulations. The basal cells (120) produce a continuing supply of keratinocytes, which are the microscopic components of the epidermis (105). Specialized cells called melanocytes (125), also reside in the basal cell (120) layer and produce the pigment melanin (130). Although some of the melanin (130) migrates toward the surface of the skin with the keratinocytes, the greatest concentration of melanin (130) remains in the basal cell layer (120). The uppermost layer of the dermis (110), which is adjacent to the basal cell layer (120), is known as the papillary dermis, and the papillae range in width from 25-100 µm, separated by rete ridges ("valleys") of comparable width.
  • Removal of the epidermis (105) eliminates superficial sun damage, including keratoses, lentigenes, and fine wrinkling. Removal of the most superficial portions of the dermis (110), i.e. the uppermost papillary dermis, eliminates solar elastosis and ameliorates wrinkling, with little or no scarring.
  • One treatment that is currently very popular uses a short pulse carbon dioxide (CO.) laser to coagulate a layer of skin to a depth of -50-100 µm /pulse. This treatment is sometimes referred to as a "laser peel". CO2 laser radiation (in the 9 - 11 µm region of the infrared) is strongly absorbed by water (contained in all tissue). When the energy/unit volume absorbed by the tissue is sufficient to vapourize the water, a microscopically thin layer of tissue at the surface of the irradiated region is rendered necrotic; (see e.g., R. M. Adrian, "Concepts in Ultrapulse Laser Resurfacing", URL - http://www.lasersurgery.com/physicians.html (1996)). The skin is coagulated on the surface of the region irradiated by the infrared beam from the CO2 laser. After irradiation, the dehydrated, necrotic surface layer is mechanically removed, and additional irradiation takes place, this process being repeated until the desired depth of tissue is removed. In medical terms, tissue is removed with less collateral damage than with other modalities, e.g., liquid nitrogen, cautery, chemical peels; (see e.g., E. V. Ross et al, "Long-term results after CO2 laser skin resurfacing: a comparison of scanned and pulsed systems", J Amer Acad Dermatology 37: 709-718 (1997)).
  • The radiation features that result in reduced collateral damage are: a wavelength that is strongly (optically) absorbed; and a pulse duration that is short compared to the time for deposited energy to diffuse into the surrounding tissue; (see e.g., R. J. Lane, J. J. Wynne, and R. G. Geronemus, "Ultraviolet Laser Ablation of Skin: Healing Studies and a Thermal Model", Lasers in Surgery and Medicine 6: 504-513 (1987)). The short pulse CO laser, with an absorption coefficient in tissue of -1/50 µm-1 and a pulse duration of -10-100 ns, leads to a reduction of collateral damage as compared to a continuous wave (cw) CO2 laser or lasers at other visible and near infrared wavelengths. But clinical results on patients treated for the elimination of wrinkles with the short pulse CO2 laser show an abundance of undesirable aftereffects, including erythema (red, inflamed skin) and crusting, with the possible formation of scar tissue and dyspigmentation (see e.g., Andrew Bowser, "Addressing Complications from Laser Resurfacing-Deep scarring and insufficient follow-up are among causes cited", Dermatology Times 18, No. 9: 50-51 (Sept. 1997)). One problem with the pulsed CO2 laser is that the radiation absorption depth is not shallow enough. Another is the deposited laser energy is not sufficiently removed from the surface to completely prevent collateral damage. As a result, this modality for "superficial skin peel" can be relatively painful, often requiring general anesthesia and a prolonged recovery period.
  • A newer treatment that is gaining in popularity uses a pulsed erbium YAG (Er:YAG) laser, emitting radiation at 2.94 µm in the infrared, where water absorption is even stronger than at CO2 wavelengths. Er:YAG light is approximately 10 times more strongly absorbed in skin than CO2 laser light. When compared to the effect of CO2 laser irradiation, a shallower layer of skin absorbs the radiation and is vaporized and ablated from the surface, leaving a thinner thermally damaged and coagulated layer adjacent to the removed tissue. Damage has not been observed to exceed a depth of -50 µm of collagen denaturation. (See e.g., R. Kaufmann and R. Hibst, "Pulsed Erbium: YAG Laser Ablation in Cutaneous Surgery", Lasers in Surgery and Medicine 19: 324-330(1996)).
  • Treatment with the Er:YAG laser rejuvenates skin, with less pain, less inflammation, and more rapid healing than treatment with the CO2 laser. The depth of penetration with the Er:YAG laser, being shallower, does not thermally stimulate new collagen growth as much as the CO2 laser, so fine wrinkles are not eradicated as effectively. Dermatologists and cosmetic surgeons are finding the Er:YAG laser preferable for younger patients who have superficial skin damage but less wrinkling, while the CO2 laser is thought to be preferable for older patients who want to have fine wrinkles removed around the lips and the eyes (see e.g., Betsy Bates, "Dermatologists Give Er:YAG Laser Mixed Reviews", Skin & Allergy News 28, No. 11: 42 (Nov. 1997)). Although the depth of penetration is shallower and the skin is actually ablated rather than just rendered necrotic, the ablation depth and the depth of coagulated skin limits the precision with which the Er:YAG can remove epidermal tissue without damaging the underlying papillary dermis. And while pain is lessened, many patients still require some sort of anesthesia during treatment and the application of a topical antibiotic/antimicrobial agent following treatment to prevent infection during healing.
  • It is also generally known in the art to use ultraviolet wavelength lasers for medical and dental applications. See e.g., US Patent 4,784,135 , issued 11/15/88 , entitled "Far Ultraviolet Surgical and Dental Procedures", by Blum, Srinivasan, and Wynne. See also US Patent 5,435,724 , entitled "Dental Procedures and Apparatus Using Pulsed Ultraviolet radiation", issued 7/25/95 to Goodman, Wynne, Kaufman and Jacobs.
  • Document WO 96/28212 describes a surgical system according to the preamble of claim 1 of the present invention.
  • The need remains for an apparatus which provides for skin resurfacing in a painless environment with exquisite control and markedly decreased morbidity by eliminating erythema and scarring. There is also a need for an apparatus and method of using ultraviolet (uv) light, delivered in a finely-controlled, countable number of short pulses with sufficient fluence to ablate skin, to remove thin layers of skin at the site of irradiation, with exquisite lateral precision and depth control, resulting in minimal damage to the skin surrounding and underlying the ablated area. The present invention addresses these needs.
  • There is also a need for an apparatus and process which enables a controlled removal of the epidermis down to the papillary dermis, adapting to the undulations of the papillary dermis. The present invention addresses such a need.
  • Disclosure of the Invention
  • In accordance with the aforementioned needs, the present invention is directed to a system (called a Dermablator) that can be used to carry out an improved "laser peel" of the skin. The present invention is used in a process, Dermablation, that leads to clean, precise removal of surface skin while minimizing collateral damage to the skin underlying the treated region.
  • An example of a surgical system for removing skin having features of the present invention includes: a pulsed light source capable of delivering a fluence F exceeding an ablation threshold fluence F th ; and a control mechanism, coupled to the light source, for directing light from the light source to locations on the skin and determining if a skin location has been ablated to a desired depth.
  • The light source is a laser, for example: an argon fluoride (ArF) laser having a wavelength of approximately 193 nm.
  • The present invention has other features which limit the depth of ablation by utilizing feedback from the physiology of the skin, namely the infusion of blood into the area of excision when skin has been ablated to a sufficient depth to produce bleeding. The infusion of blood can act as a "stop" to prevent further ablation, thereby effectively terminating the dermablation. The blood can then be removed by washing it away with physiological saline solution, clearing the area for further treatment.
  • The system of the present invention utilizes a laser having a relatively low blood absorption characteristic, such as an ArF laser, to ablate the skin to a sufficient depth to produce bleeding. A second laser, such as a uv light source with a different wavelength and a relatively high blood absorption characteristic, is then utilized to penetrate the blood, heating it sufficiently to coagulate the blood, stemming subsequent bleeding, yet leaving the tissue with an intact ability to heal without the formation of scar tissue.
  • The system further comprises: a coagulating light source having a different wavelength than the ArF laser and a relatively high blood absorption characteristic; means for detecting the appearance of blood at a given skin location; and means for switching to the coagulating light source, in response to the detection of blood at a given skin location.
  • Examples of the coagulating light source include a krypton fluoride (KrF) laser having a wavelength of approximately 248 nm; a xenon chloride (XeCl) laser having a wavelength of approximately 308 nm; and a xenon fluoride (XeF) laser having a wavelength of approximately 351 nm.
  • The present invention has still other features which provide precise lateral and depth control, permitting the epidermis to be removed down to the papillary dermis, following the undulations of the papillary dermis, so that the papillae are not penetrated even though the epidermis is removed in the adjacent rete ridges. This lateral and depth control may be accomplished by using careful observation, assisted by spectroscopic detection, to identify when the epidermis has been removed, exposing the underlying dermis, with spatial resolution appropriate for the spacing of the undulations of the papillary dermis.
  • The lateral and depth control of the present invention is one advantage over prior art laser peels operating at wavelengths which lead to thermal damage in the tissue underlying the ablated region that renders this underlying tissue denatured and coagulated. For example, the use of current CO2 lasers make it difficult if not impossible to determine how deep the ablation has penetrated based on real-time observation and/or feedback control.
  • Accordingly, the present invention has yet other features which provide a feedback control mechanism which utilizes the optical characteristics such as the colour, appearance and remittance of the definable skin layers. Using ultraviolet light ablation, the tissue underlying the ablated region will retain its undamaged morphology and colour, permitting real-time determination of whether the ablation has proceeded to the correct depth, e.g., to or just beyond the epidermal-dermal interface.
  • Another example not according to the present invention includes a means for controllably abalating the skin by detecting a colour change near or at the epidermal/dermal boundary. The control mechanism could be a feedback control mechanism, comprising: a second light source illuminating the skin; and at least one photodetector having an input and an output; the input receiving scattered/reflected/fluoresced light from the second light source, and the output providing a feedback signal to the system causing the light source to be inhibited at a given location, in response to the second light source at the input. Examples of the second light source include a visible light source; an infrared light source; and an ambient light source. Another example of the second light source is one which is both relatively highly absorbed by epidermal melanin and relatively highly remitted by a dermal layer.
  • Furthermore, the present invention has features that serve to automate the removal of skin, wherein the ablating laser beam can be scanned accurately and repeatably over a designated area of skin under the control of a computer system which utilizes real-time observation and/or feedback to control the depth of ablation at each location. The areas to be scanned may be designated by an adjunct visible alignment laser, employing an input device to scan the alignment beam over the area of skin to be treated and recording the beam positions for subsequent automatic scan of the ablating laser beam over the same scan domain. Alternatively, the area of treatment may be specified by recording its image with a camera and designating on the digital image the locations to be treated.
  • An example of an automated system having features of the present invention includes an alignment and recording mechanism, comprising: a visible laser emitting a beam illuminating the skin at a location coincident with the ablating light; means for scanning the beam across the locations on the skin; and means for recording scanned beam positions, coupled to the means for scanning, for subsequent automatic scan of an ablating light source across the locations on the skin.
  • An example of the computer and control mechanism includes: one or more rotatable mirrors, the mirrors positioned in the light source path for controllably scanning the light source; one or more motors, coupled to the mirrors, for angularly rotating and feeding back angular positions of the one or more mirrors; and a computer, coupled to the light source and the motors for controlling the motors and selectively shuttering the light source at a given location on the skin.
  • In yet another example, the computer includes a feedback control system, coupled to the light source for selectively shuttering the light source at a given location on the skin. The shuttering mechanism could be an active mask array, coupled to the feedback control system, for selectively shuttering the light source at a given location that has been ablated to the desired depth.
  • Still another example of the present invention is a robot/laser system, further including a camera for visualizing an image of the locations on the skin; a computer, coupled to the camera, the computer having an output for displaying and an input for designating the locations of the skin to which the laser is directed.
  • Preferably, the robot/laser system further includes: one or more rotatable mirrors, the mirrors positioned in the light source path for controllably scanning the light source; one or more motors, coupled to the mirrors, for angularly rotating and feeding back angular positions of the one or more mirrors; a second light source illuminating the skin being ablated, wherein light from the second light source is scattered/reflected/fluoresced from the ablated location; a photodetector having an input and an output; the input for receiving the light from the second light source; and the output coupled to the system and providing a feedback signal to the system for inhibiting the pulsed light source at a given location.
  • Preferably the robot/laser system includes a registration mechanism for relating coordinates of a point in one patient coordinate frame of reference to a corresponding position in the robot/laser frame of reference. An example of the registration mechanism includes means for attaching fiducials to the skin; a movable tracking laser, coupled to the computer, for recording 3D coordinates of the fiducials; and triangulation means, for establishing 3D locations of the fiducials in the tracking laser frame of reference. Another example of the registration mechanism comprises: means for relating points corresponding to an area of skin in the patient frame of reference subsequent to a change in position, to the same area of skin in a patient frame of reference prior to said change in position. Yet another example of the registration mechanism comprises means for accurately directing the light source by relating points on an area of skin defined in a digital image, to an area of skin on the patient.
  • An alternative registration mechanism comprises: means for attaching fiducials to the skin; a pair of cameras, coupled to the computer and mounted at fixed positions relative to the robot/laser system for recording coordinates of the fiducials; calibration means for relating the fixed positions of the cameras to the robot/laser system from a predetermined calibration transformation; and a camera model for mapping the relationship between each location in 2D camera images and a set of 3D points in an imaged space that map to it.
  • Another example a robot/laser system of the present invention includes: a camera for visualizing an image of the locations on the skin; a computer, coupled to the camera, the computer having an output for displaying and an input for designating the locations of the skin to which the laser is directed; a flexible optical fibre bundle having an output end and an input end, the output end being attached to a mask for affixing to the patient and the input end adapted for receiving the light source in a predetermined manner; and a removable mirror located adjacent to the input end for viewing the skin through the fibre bundle using the camera.
  • In addition to serving to remove cosmetic defects, i.e. seborrheic keratoses and lentigenes, the Dermablator/Dermablation can provide a modality to treat other pathologies of the epidermis, including Bowen s disease, exophytic warts, flat warts, lichen-planus-like keratosis (LPLK), and actinic keratoses. Thus, this invention provides an apparatus and process for treating a wide range of common skin conditions.
  • Furthermore, there are many other applications of this invention: (i) The precise superficial capability of Dermablation allows tissue to be "marked", i.e., scored with an identifying mark, either on the patient or on biopsy samples; (ii) Localized fungal infection of the toenail may be treated by ablating the infected region to the desired depth without damaging underlying tissue; (iii) Burn eschar (the result of a serious burn) may be removed by ablating it with the Dermablator, following the variable thickness of the eschar and stopping at each location as soon as healthy, viable tissue is uncovered; (iv) Malignant melanoma may be removed by Dermablation with elimination of surgically-induced metastasis, i.e., no viable cancer cells will be released into the patient's system; (v) Patients with bacterial or viral infection (e.g., AIDS) may be treated with no danger that the tissue ablated from the surface will contain viable viral particles or other microbes, since Dermablation decomposes the ablated material into small inert molecular or atomic fragments; (vi) Patients with the rare condition of Epidermolysis Bullosa, whose delicate skin is incapable of repairing itself following even minor surface cuts and wounds, can have epidermal lesions removed by Dermablation without compromising their fragile dermis; and (vii) Eyelid lesions at the tarsal margin, such as hydrocystoma and Chalazion (sty), may be treated with great precision, resulting in minimal damage to the eyelashes and minimizing the likelihood of notches or other depressions in the tarsal margin that can interfere with tear flow and mucous distribution on the inner surface of the eyelid.
  • An additional application is to use Dermablation to remove a basal cell carcinoma. Here, the lesion can be selectively marked with an exogenous agent that provides contrast between the lesion and surrounding healthy tissue. Basal cell carcinomas are differentiated from surrounding tissue in biopsy specimens by standard histological treatment, i.e., staining the tissue with chemicals. Such histology is used to make the diagnosis of basal cell carcinoma in the biopsy. Staining agents can be applied directly on the patient, providing a visible differentiation of the basal cell carcinoma, such differentiation being used to guide the Dermablator to remove the lesion with minimal collateral damage.
  • The system of the present invention is used in a method for removing skin comprising the steps of:
    • directing light from the light source to locations on the skin;
    • controllably determining if a skin location has been ablated to a desired depth;
    further comprising the steps of: detecting the appearance of blood at a given skin location; and switching to a coagulating light source (820), in response to the detection of blood a given skin location, wherein providing the coagulating light source has a different wavelength than the ArF laser and a relatively high blood absorption characteristic.
  • Preferably the system of present invention can be used in a method as described above, wherein said controllably determining step comprises the step of controllably ablating the epidermis along the contours of an epidermal/dermal boundary.
  • Preferably the controllably determining step further comprises the step of detecting a colour change near or at the epidermal/dermal boundary.
  • Preferably a method of use of the device of the present invention, further comprises the steps of: controllably scanning the light source across the skin; and selectively shuttering the light source at a given location on the skin when it has been ablated to the desired depth.
  • Preferably a method of use of the device of the present invention further comprises the steps of: illuminating the skin with a beam from a visible laser at a location coincident with the ablating light; scanning the beam across the locations on the skin; recording scanned beam positions, in response to said scanning step; and automatically scanning of an ablating light source across the locations on the skin, in response to said recording step.
  • Brief Description of the Drawings
  • The invention will now be described, by way of example only, with reference to the accompanying drawings, in which:
    • Figure 1 depicts an cross section of normal human skin;
    • Figure 2 depicts a form of the apparatus constructed in accordance with the present invention;
    • Figure 3 depicts a form of the apparatus constructed in accordance with the present invention;
    • Figure 4A depicts a form of the apparatus including the surgeon interacting directly with the patient in accordance with the present invention;
    • Figure 4B depicts a form of the apparatus including a means of scanning the laser beam in accordance with the present invention;
    • Figure 4C depicts a form of the apparatus including the surgeon interacting with the patient via a remote mechanism in accordance with the present invention;
    • Figure 5 depicts a form of the apparatus including the surgeon interacting with the patient via a remote mechanism in accordance with the present invention;
    • Figure 6 is a diagram helpful in explaining the operation of the apparatus of Figure 4C and Figure 5; and
    • Figures 7, 8, and 10 depict examples of an apparatus constructed in accordance with the present invention.
    • Figure 9 illustrates an apparatus not part of the present invention.
    Detailed Description
  • By way of overview, UV light removes thin layers of tissue at a rate that depends on the fluence F of the light. There is a threshold fluence F th , and areas at the surface of the tissue that are irradiated with a F exceeding F th are ablated to a depth of approximately 1 µm for each (short) pulse of light. The unablated tissue underlying and adjacent to the ablated area absorbs some light and is damaged to a depth of somewhat less than 1 µm, essentially to sub-cellular depth. Successive light pulses remove additional thin, layers, and after the last pulse there is only an ultra-thin, sub-cellular layer of tissue at the margins of the ablated region that experiences damage. Thus, collateral damage is intrinsically minimized. The surgeon or medical practitioner needs a source of light delivering F > F th and a delivery tool. The source might be a far UV pulsed laser, such as an excimer laser. Different excimer lasers emit radiation at different wavelengths, which ablate tissue to different depths and with different F th. Well-known far uv excimer laser systems include XeF at 351 nm, XeCl at 308 nm, KrF at 248 nm, and ArF at 193 nm. All excimer laser systems have been shown to be capable of emitting pulses of far uv light that exceed ablation threshold for human (and animal) tissue, including skin.
  • Figure 2 depicts an example of an apparatus having features of the present invention. As depicted, the delivery tool might be a "pipe" 205 through which the light beam 210 is transmitted from source to tissue, with an adjustable steering mirror 215 to direct the beam around corners and an adjustable lens/masking system, such as lens 220 and slit 225 at the delivery end, to shape the light beam into the desired pattern where it irradiates the tissue.
  • Figure 3 depicts another example of an apparatus having features of the present invention. As depicted, the delivery tool might be an optical fibre, or a fibre bundle 305 terminated by a hand-held tool 310 that the physician or technician can manipulate to deliver the light beam to the skin area to be irradiated.
  • Referring now to Figures 1 and 2, the delivery tool of Fig. 2 can be adjusted to focus the uv irradiation beam to an area small in comparison to the cross-sectional area of a rete ridge of the epidermis. Then the beam can irradiate the area until the epidermis is completely removed, before the beam is scanned/displaced to an adjacent area where the procedure is repeated, ablating this new area of epidermis down to the dermis. In this way the contours of the irregular epidermal/dermal interface can be taken into account. By scanning the uv laser beam across an area of skin in this manner, only epidermis will be removed, with depth precision that mirrors the contours of the papillae of the papillary dermis.
  • As will be discussed in more detail below, one aspect of the present invention employs a unique detection scheme to enable a precisely contoured removal of tissue. The epidermis has melanin and thereby is coloured, whereas the dermis is white. For example, the medical practitioner can watch the ablated site for the appearance of white dermal tissue.
  • As depicted in Figure 4A, the skin to be irradiated 405 can also be defined by covering the area with a masking material that blocks/absorbs/reflects radiation except at the desired location for the tissue ablation. The masking material 410 could even be made of an erodable material and fabricated with variable thickness, so that a homogenous light beam erodes away the material and ablates skin under the mask only after it has eroded entirely through the mask. Thus, different areas of tissue would receive different "doses" of radiation, producing areas of treated skin with the depth of the ablation controlled by the careful fabrication of the erodable mask. The mask could be impregnated with a marker material, e.g., a fluorescent dye, that would give a clearly recognizable signal when the mask was being eroded, such signal ceasing as soon as the mask was entirely eroded through. Alternatively, the "masking" could be accomplished by applying a "sunscreen" cream or ointment, e.g. zinc oxide, to cover areas where tissue ablation is not wanted. This sunscreen would have to be of sufficient thickness so that it is not completely eroded through to the underlying skin during the treatment.
  • A robot/laser system can serve to scan an ablating laser beam to deliver a precisely controlled number of pulses to each location on the area of skin being irradiated. Figure 4B depicts an example of such a robot/laser system having features of the present invention. The analogy is to a raster scan of an electron beam in a cathode ray tube (TV) display. The amount of energy, or number of pulses, delivered during one scan (or pass) of the laser beam is small enough so that an appropriate dose can be applied to each location by varying the number of times the area is scanned. In contrast, for enhanced speed of tissue removal, one could initially deliver a larger amount of energy per scan, sacrificing precision of depth control, and getting close to the desired depth. Then, successive scans could be carried out at progressively less laser energy, providing increased precision of depth control and allowing the surgeon the fine control to zero in on the desired depth of tissue removal. Whether the surgeon chooses to vary the laser energy or not between scans, one scan could consist of one laser pulse for each location of irradiated tissue or many pulses for each location, the number of pulses being selected to remove tissue to a desired depth. One example is a stationary laser 415 emitting a beam that is guided by a computer-controlled mechanism. As depicted, one such mechanism could be a pair of mirrors 420 rotating on axes at right angles to one another. The mirrors could be controlled by motors (not shown) having position encoders that enable precise, digital designation of the mirror angles of rotation 430. The motors can be controlled through a standard A/D, D/A circuitry interfaced with a computer 425 running standard servo-control software. The motor encoder information provides the necessary positioning information for fine control. This system is preferably engineered to be capable of accurate positioning of the laser beam on the skin to within 25 µm at a typical target distance of 0.5 m. The control scheme, encoders, motors, mechanical accuracy, and distance from target all affect the overall precision. We assume that the robot has been calibrated, and the forward and inverse kinematics are known with sufficient precision to meet these accuracy requirements.
  • The system (examples of which are described below) is preferably capable of positioning the laser beam with the required precision at any location on the (irregular) surface of the skin.
  • The surgeon can set the area scanned by the laser by using several possible techniques. For example, the surgeon can affix a physical mask or plate on the robot/laser system that restricts the range of mirror angles for which the beam escapes the laser device. Alternatively, the surgeon could set the extent of the range of the mirror angles by interacting with the controller software through a user input device such as a keyboard, mouse, or joystick. Once the surgeon has fixed the scan area, he can verify that it is what he intended by instructing the laser system to scan using visible light. This allows the surgeon to preview the region to be scanned by the laser. If the scanned area is not appropriate, the surgeon can reposition the patient or adjust the range of the laser as described above.
  • In addition to being able to deliver uv laser energy sufficient for tissue ablation at these locations, the system can illuminate the area to be treated with light visible to the human eye or to an electronic detector or imaging detector array. This visible light serves to align the system by illuminating the tissue at the same location where the ablating uv beam strikes the tissue, when the uv is not otherwise shuttered or turned off. Alternatively, the system can be a two degrees of freedom (2DOF) robotic device that can accurately and repeatably scan a laser beam over a designated area of skin. The system could be a 2DOF robotic arm with a laser beam emerging from the delivery end.
  • In the following versions of the present invention, the robot/laser system can be programmed to: (i) systematically visit every location within a designated area in succession (full raster scan); (ii) visit only certain locations of interest on the skin surface; or (iii) perform a full raster scan with the exclusion of certain designated regions within the full area being scanned. For each of these scenarios, the general procedure is to alternate between (a) designating regions of tissue to be irradiated and (b) exposing these regions of interest to laser energy, thereby removing a thin layer of tissue, with steps (a) and (b) being repeated until the treatment is complete.
  • Scenario (i): systematically visiting every location in succession, while protecting certain locations from tissue ablation by use of a physical mask. Referring again to Figure 4A, the robot/laser system 400 is capable of emitting two different laser beams, a uv radiation laser for ablation and a visible laser for alignment. With the uv radiation laser source shuttered, the surgeon scans the visible alignment beam 412 across the area of skin to be treated, thereby designating the area for the system control mechanism. The surgeon then applies a physical mask or masking material 410 to those regions 406 within the area that will be illuminated during the ablation scan but which are not to receive treatment, i.e. not to be ablated. The mask might be made of a reflective material, thereby directing the uv laser energy away from the underlying skin. Alternatively, it could be made of an absorbing material with a threshold for ablation greater than that of skin. Yet another alternative is the absorbing material might be of sufficient thickness that the process does not erode all the way through the mask. Next, the surgeon opens the shutter, admitting the uv radiation and uses that radiation to scan the designated area 407. Following a full scan, the surgeon assesses the irradiated area. A masking material can then be applied to those regions where no more tissue should be removed. The surgeon then repeats this process until all locations to be treated have been ablated to the desired depth, with the masked-off region expanding with each iteration. Since the locations to be ablated are distinguished by a physical mask from the adjacent locations that are not to be ablated, minor patient motion can be tolerated during all phases of the procedure.
  • Scenario (ii): visiting only certain locations within the larger area to be treated, protecting other locations within that larger area from ablation by an "electronic shutter". Figure 4C depicts an example of a computer-controlled robot/laser system 402 in accordance with the present invention capable of emitting two different laser beams: a uv radiation laser for ablation; and a visible laser for alignment. The surgeon can, as before, designate the locations to be ablated by using an alignment light 412 to define these locations. The alignment light can be pointed and moved to outline the locations of skin to be treated. Additionally, a phosphorescent material can be applied to make the outlined region easier to read. An input device 450 such as a joystick, mouse, or force-torque sensor, can be used to translate the surgeon's hand motion into motion commands for servo motors controlling the visible beam position. It is well known in the art of computer-integrated surgery to record in a computer the specific point locations on or in a patient using a multitude or variety of 3D localizing technologies, e.g., mechanical pointing devices. See e.g., Computer-integrated Surgery: Technology and Clinical Applications, Russell H. Taylor et al., (editors), The MIT Press, pp. 5-19,(1996) (hereinafter "Computer Surgery"). According to the present invention, a robot/laser system preferably includes computer software for recording the visible beam positions which have been designated by the surgeon for subsequent "playback" using the ablating laser. In essence, the surgeon outlines the locations to be ablated directly on the patient's skin by using the visible light beam as a "drawing" tool.
  • A complete procedure may involve many iterations. As an initial step, the surgeon can use the visible light 412 to position the system. The area of interest 455 can then be outlined. At this point, these locations can be previewed in visible light or the system switched to ablation mode and directed to deliver controlled treatment of these locations. Note that the patient should not move from the time the surgeon designates the locations of interest to the time the ablation scan is completed. The patient is then free to move. For the next iteration, new areas of interest can be designated, which may or may not overlap the previous locations, and the process repeated. This procedure is repeated for as many times as it takes to ablate all of the designated locations of skin to the desired depths. The surgeon is typically making decisions from iteration to iteration.
  • In many cases, the area being treated can require many iterations to attain the full treatment and if the patient moves between iterations, the treatment region must be re-designated by the surgeon. This may become tedious, slow and lead to inaccurate treatment. Thus, it is desirable to develop a registration, well known in the art, between the area of treatment on the patient and the coordinate frame of the robot (see e.g., Computer Surgery, pp. 75-97). A more detailed example of a registration technique in accordance with the present invention follows in scenario (iii), but briefly, the region can be registered to the patient by determining the three-dimensional (3D) position of the area of skin surface to be treated. This surface area is then tracked when the patient moves. The result is that a location of treatment designated by the surgeon can be identified by the system, from iteration to iteration, even though the patient moves, without active re-designation by the surgeon. This same capability allows the surgeon to build up a complicated pattern of treatment over successive iterations. For example, the surgeon can re-irradiate a region of locations previously irradiated with the additional specification of a region within the larger region that will be "electronically masked off".
  • Scenario (iii): systematically scanning an ablating uv laser over an area while automatically "shuttering" the laser when certain locations (for which no further ablation is desired) are in the target area. Figure 5 depicts an example of a computer assisted UV Dermablator system having features of the present invention. As depicted, a surgeon can designate locations of interest on a digital image 500 of a patient 505 on a computer display 510, rather than directly on the patient. This will make the region-editing functions easier to use. A camera 515 can be mounted on the system such that the area of skin to be treated is within its field of view. The system is preferably configured so that a digital image is available to a computer 525 for display, image processing, and interaction. To maintain a correspondence between the area designated in the camera image 500 and the area that will be scanned 530 by the ablating laser 550, these two areas must be registered with respect to one another. (Registration is described below).
  • By way of overview, the surgeon can use a visible alignment light to illuminate the patient and carry out a scan in order to get an appropriate initial placement of the system relative to the patient. The surgeon then records ("snaps") an image of the patient. Then, an automatic (or semiautomatic) registration can be performed to align the laser system with the camera image. Now the patient must not move until a scan with the ablating uv laser is complete. Using a mouse, joystick, or touch screen, the surgeon designates on the digital image the locations to be treated. Working with this digital image makes available the full graphics power of the computer to provide a richer pallet of editing techniques, such as area growing, area shrinking, inversion, outlining, colour discrimination, etc. The surgeon can then treat the designated locations using the ablating laser. The patient may then move. The process is then repeated for additional iterations (snap image, register, designate locations, ablate) until the surgeon determines that treatment is complete.
  • Registration: Scenarios (ii) and (iii) can call for some sort of registration to relate the coordinates of a point in one coordinate frame of reference to its corresponding position in a different coordinate frame of reference. In scenario (ii), the points corresponding to an area of skin on the patient (in the patient s current position) may need to be related to the area of skin defined earlier (before the patient moved). In scenario (iii), an area of skin defined in a digital image must to be related to an area of skin on the patient, so that the ablating laser beam can be accurately aimed.
  • Consider scenario (ii) with reference to Figure 6, which depicts an example of the frames of reference and transformations between these frames of reference needed for registration in accordance with the present invention. To enable registration of an area of skin after patient movement with that same area of skin before movement, one first defines that area of skin with respect to a coordinate system "P" attached to the patient. That coordinate system is then reregistered by a visible tracking laser 605 mounted on the robot/laser system, relative to 660 the coordinate frame "R" associated with the robot/laser system. Such registration can be accomplished by attaching several markers, or fiducials 610, to the patient, pointing the tracking laser beam 607 at each fiducial while the tracking laser is in one mounting position, moving the tracking laser to a second mounting position, and repeating the pointing process, thereby establishing the 3D locations of each fiducial in R through triangulation. The use of robot-assisted surgery and in particular fiducial markers for registration is well known in the art. See e.g., Kazanzides, et al, "An Integrated System for Cementless Hip Replacement," IEEE Engineering in Medicine and Biology Magazine 14, pp. 307-313 (1995).
  • In greater detail, the patient coordinate frame P is defined in terms of the fiducials 610. This reference frame P is an orthonormal basis made up of the vectors x, y and z. For example, the x-axis of the patient coordinate frame P might be a vector formed by a line from a first fiducial f1 to a second fiducial f, with f1 serving as the origin of frame P. Additional fiducials might be placed at locations f3 and f4. With the 3D locations of the fiducials 610 established in reference frame R, Gram -Schmidt orthogonalization may be used to define y and z in terms of x and the coordinates of the fiducials 610 (in R). A description of this orthogonalization procedure is given in Edwards and Penney, Elementary Linear Algebra, pp. 241-242, Prentice-Hall, Englewood Cliffs, NJ, (1988). The transformation RTP, between the two frames of reference, P and R, can then be computed in a straightforward manner. Any time the patient moves, for example from position 0 to position 1, the patient frame changes from P0 to P1, and a new transformation RTP can be established through triangulation.
  • The area of interest in the patient frame of reference is defined by constructing a surface 620 passing through the fiducials (the "fiducial surface"). When the surgeon identifies an area of interest with the tracking laser, this beam will intersect the fiducial surface 620 at a set of locations 625. The set of 3D points corresponding to these intersections is fixed in the patient coordinate frame P, even when the patient moves. So, to register an area of interest after the patient moves, only the transformation RTP for the new position of the fiducials need be computed. Registration in scenario (iii) with a camera recording digital images of the patient has many similarities to scenario (ii). Again, the area of interest is defined in terms of the patient coordinate frame P by the intersection of the alignment laser and a surface 620 constructed through the known fiducial positions 610 and the locations of intersection 625. The main difference is that the positions of the fiducials is determined by triangulation using two cameras 630 instead of using two different positions of a tracking laser. The cameras can be mounted at fixed positions relative to the robot/laser frame 660. Their position (the measurement frame "M") relative to the robot/laser frame 660 is known from a calibration transformation MTR determined prior to the medical procedure and does not change in the course of this procedure. Those skilled in the art will appreciate that alternatively, one camera could be used by moving it to two different positions. An accurate camera model has preferably also been built prior to the procedure, so that the relationship is known between each location (pixel) in the 2D camera image and the set of 3D points (within a cone) that map to it. Given this camera model, when the surgeon snaps the images, a pair of stereo images is captured and made accessible to a computer (not shown). Well known image processing techniques can be used to identify the fiducials 610 and to establish the coordinate axes (x,y,z) of the patient frame of reference P. Ambiguity in establishing the correspondence between fiducial images in the pair of camera images (e.g., if one fiducial is obscured by the second fiducial in one image of the pair while both fiducials give distinct points in the second image) may be resolved by the surgeon based on his visual observation of the patient. (See e.g., D. H. Ballard and C. M. Brown, Computer Vision (Prentice-Hall, Englewood Cliffs, NJ, 1982), pp. 88-93). The surgeon can then designate an area of interest directly on one of the images on a computer screen, as described above. As in the registration scenario (ii), the system translates this designation into the area of interest in the patient frame P. The system is then capable of following this surgical plan, i.e. determining the set of robot/laser ablation locations that correspond to the region designated on the screen.
  • Alternative means to using the cameras 630 for locating the fiducials 610 include the use of a 3D digitizer 640 (an array of cameras that optically tracks light-emitting diode markers affixed to the patient), e.g., an OPTOTRAK device (manufactured by Northern Digital, Inc., Canada) (see. e.g. R. H. Taylor et al, "An overview of computer-integrated surgery at the IBM Thomas J. Watson Research Centre", IBM J Research and Development 40, p. 172 (1996)) or of a calibrated pointing device 650 (a mechanically manipulated pointer to reach out and point to the fiducials 610), e.g., the VIEWING WAND (manufactured by ISG Technologies, Inc., Canada). Several safety features can be built into the UV Dermablator. The surgeon makes the decision as to which area of skin to treat and how many pulses of light are to fall on each location of tissue. He can then set the robot/laser system on "automatic pilot". But the surgeon will be watching the procedure and can intervene at any time, taking "manual" control of the system. This is analogous to putting an automobile in cruise control once a cruising speed is selected, but having the ability to instantly take back control by touching the brake pedal.
  • Also, insofar as a computer is being used to control the delivery of ablating energy to the patient's skin, each location of skin being irradiated can be labelled and its history recorded by the computer. Then, with a safety threshold set in advance, the system will not deliver pulses in excess of that threshold without an explicit command by the surgeon.
  • Figure 7 depicts an example of an alternative system in accordance with the present invention for delivering laser energy to the patient's skin while permitting the patient to move throughout the procedure. As depicted, the system includes an optical fibre bundle 710, one end of which is clamped to a mask 715 worn by the patient while the other end, the input end 720, is scanned by an ablating laser beam 725 in a predetermined manner. The fibre bundle 710 is preferably flexible and abuts the patient's skin. The surgeon can look at the skin through the input end 720 of the fibre bundle 710, using, for example, a mirror 730 that snaps into position for viewing. This mirror 730 snaps out of the way for ablation, working like the mirror in a single lens reflex (SLR) camera. With the viewing mirror in place, a camera 735 can view the patients skin, deliver its image 750 to a computer 740 and computer display 745, and the surgeon can mark the areas to be treated as described in scenario (iii). With the viewing mirror 730 displaced, the ablation can proceed, the laser 700 scanning across the input end 720 of the fibre 710 in a predetermined pattern. Successive viewing, marking, and ablation iterations are carried out until the procedure is completed to the surgeon's satisfaction. Use of this fibre bundle 710 eliminates the need for re-registration between each iteration, because the output end of the bundle does not move relative to the patient during the procedure.
  • Process - UV Dermablation: The ablation of skin by pulsed uv light in accordance with the present invention can remove epidermal tissue with minimal damage to the underlying dermis and minimal scar tissue and erythema. Since each pulse of uv light removes less than a cellular layer of tissue, it is possible to control the procedure with great precision, ablating the skin to the desired depth and no more.
  • In a preferred embodiment, the skin is ablated to a depth where bleeding just commences, with no deeper penetration. So a process is needed to stop the ablation as soon as bleeding is detected. Alternatively, the process can be slowed at the first hint of bleeding and brought to a complete halt at an additional, adjustable predetermined depth, depending on the patient's skin condition. Referring again to Figure 1A, the dermis, which is much thicker than the epidermis (up to 4 mm thick), has fewer cells, and is mostly connective tissue or fibres. Blood vessels course through the dermis. The skin is vastly perfused with blood. The mean blood flow is many times greater than the minimum flow necessary for skin cell nutrition because cutaneous blood flow serves as a heat regulator of the entire organism. Thus blood is plentiful and flowing at depths just below the basement membrane. Once the ablation process perforates a capillary wall, blood will perfuse into the incision.
  • For the purposes of this invention, blood differs from the surrounding dermis in one very important way: the aqueous chlorine ions in blood are a strong absorber of uv radiation at wavelengths below 200 nm, with an absorption maximum at 190 nm. This absorption differs from the absorption of uv light by cells and protein molecules in that the absorbed energy is not quickly degraded into heat. So the "salt water" that is the major component of blood will "block" the incoming uv light and attenuate or completely halt the ablation process, depending on how much blood is pooled in the cavity of the incision (The uv photon energy detaches an electron from the chlorine ion, leaving a chlorine atom and a solvated electron dissolved in the water. Eventually, on a time scale long compared to ablation and thermal diffusion times, the electrons will encounter neutral chlorine atoms and recombine to form ions, giving up the photodetachment energy to heat, but the temperature rise will be minimal and of no consequence to the viability or morphology of the tissue (see e.g., R. J. Lane, R. Linsker, J. J. Wynne, A. Torres and R. G. Geronemus, "Ultraviolet-Laser Ablation of Skin", Archives of Dermatology 121: 609-617 (1985); and E. Rabinowitch, "Electron Transfer Spectra and Their Photochemical Effect", Reviews of Modern Physics 14: 112-131 (1942)). One way to take advantage of this effect is to horizontally orient the skin surface being treated, and direct uv radiation in the spectral region of the photodetachment energy, e.g., an ArF laser radiation at 193 nm, at the target surface from above. As blood perfuses the incision, it will pool under the influence of gravity, and act as a block against further tissue ablation. Alternatively, the patient can sit in a comfortable position and the punctate blood spots that appear when capillary walls are penetrated will serve to block further ablation of tissue under the punctate blood. Since the skin being treated varies in thickness, different regions of the skin will start to bleed at different depths of penetration, but the naturally occurring bleeding will block ablation at an appropriate depth for each region of skin.
  • At various points in the Dermablation procedure, it will be desirable to remove the blood or stem the bleeding, to prevent the region of treatment from being obscured. Blood can be washed away with physiologic saline solution, but such solution will continue to act as a block against further ablation by uv radiation in the photodetachment energy spectral region, e.g., the ArF excimer laser at 193 nm. The bleeding area can also be washed by deionized water, which is transparent to radiation at the uv wavelengths of the ArF, KrF, XeCl, and XeF excimer lasers.
  • Figure 8 depicts a dual laser system having features of the present invention. As depicted, first 193 nm radiation from an ArF laser 810 can be used to ablate the skin 815 until bleeding blocks the ablation. Next the wavelength is changed (by, for example, using a second laser 820 supplied with a gas mixture producing longer wavelength light, such as KrF, XeCl or XeF) so that the radiation at the second wavelength will not be blocked by photodetachment, but will be absorbed by blood protein, heating it sufficiently to coagulate the blood. Thus, further bleeding is stemmed, yet the tissue retains an intact ability to heal without the formation of scar tissue.
  • Figure 9 depicts another example of a system not in accordance with the present invention. As depicted, evidence of bleeding can be detected using a visible illuminating laser 910 that is aimed at the skin to overlap the uv radiation 955, this visible beam 915 scattering from the rough surface of the skin being treated to form a visible "spot" that can be detected by the practitioner's eye or by a photodetector 930 mounted near the tissue being treated. When punctuate blood appears, a small fraction of the visible laser beam will reflect specularly from the surface of the liquid and a major fraction of the visible laser beam (915) will be absorbed by the pigment (hemoglobin) in the red blood cells in the blood, leading to a great reduction of the light hitting the photodetector. This reduction in signal can be fed back to the uv laser 950 power supply or to a beam shutter by a control signal 960 which terminates the surgical procedure.
  • Alternatively, instead of penetrating into the papillary dermis to a depth sufficient to induce bleeding, the complete ablation of the epidermis can be detected by monitoring for the first appearance of the white dermal boundary 925. The dermis is first revealed when the pigmented epidermis and basal cells are totally removed. For example, a focused laser beam 955 of small cross section (compared to the area of a papillae or rete ridge) can be scanned and shuttered in response to detecting white dermal tissue 920. Such colour change can be detected visually by the medical practitioner's eye. Alternatively, the colour change can be detected by the photodetector 930 monitoring the amount of scattered light from the visible laser beam 915. To improve the ability to detect the colour change in the presence of ambient lighting, the photodetector 930 might be equipped with a filter tuned to the colour of the illuminating visible laser beam 915. By limiting the detected light to the narrow spectral region around the colour of the visible laser, the detection scheme discriminates against ambient light at all other colours, thereby improving the precision with which the appearance of the dermal boundary can be detected and used for feedback to terminate the surgical procedure.
  • Figure 10 depicts another example of a laser system having features of the present invention. As depicted, a laser system 1010 can apply a laser beam 1050 over a relatively large area, encompassing many papillary contours. An active mask 1060 between the source 1010 of the beam and the skin, can be used to shutter selected areas of the beam (Fig. 10). The mask 1060 could be controlled by a detector 1070 or an array of detectors, so that each area of the skin being irradiated can provide a colour-change based feedback signal 1075 to a control system 1080 which then inhibits or shutters a section of the laser beam irradiating that area, in a one-to-one "map". Recall that the epidermis 1005 contains melanin while the dermal layer 1020 is white. This mask could be controlled electro-optically, or even be mechanically shuttered by an array of opaque flaps that rotate into the beam so as to block selected areas. The mask 1060 might be placed in the ablating laser beam 1050 at a location where the beam is relatively defocused, covering a large area. At such a location the laser beam 1050 will be of such low intensity and low fluence so as not to damage the mask. At this location, each element of the array can be relatively large. When the beam is focused by projection lenses 1065 to a smaller area 1090 on the skin, the light passing through each element will be correspondingly demagnified as well as intensified. In this way the pattern of light transmitted by the mask array may be projected to a correspondingly smaller area on the skin, yielding a transverse precision suitable for following the contours of the epidermal/dermal boundary. In addition, the focusing increases the fluence of the laser beam, ensuring that it is above threshold for ablation. In this way, the epidermis 1005 can be controllably ablated right down to the dermal boundary with great depth precision and transverse control, despite the irregular contours of the dermal/epidermal interface 1015.
  • The photodetector 1070 could be used in conjunction with and responsive to an illuminating laser 910, as depicted in Figure 9. It is known that the skin can be modeled macroscopically as a multilayered optical system (see The Science of Photomedicine, edited by James Regan and John Parrish, Plenum Press, NY, (1982), Chapter 6, pp. 147-194). The relation between sunburn protection and the degree of melanin pigmentation in the skin is well known. This is because melanin, which is present in the epidermis and is most concentrated in the basement membrane, is a strong absorber of both shorter wavelength visible light and UV radiation. In the spectral region approximately from 350 nm to 1300 nm (which includes the near UV from 350 nm to 400 nm, the visible from 400 nm to 700 nm, and the near infrared from 700 nm to 1300 nm), the epidermis can be modeled generally as an optically absorbing element while the underlying dermis acts as a diffuse reflector whose remittance increases with the wavelength. The epidermal remittance in this region is essentially due to the regular reflectance at the surface of the skin (-5% for a normally incident beam). A change (as detected by photodetector(s) (930, 1070)) in the remittance of an external (UV, visible or infrared) illuminating laser, resulting from the complete removal of the melanin-containing epidermis, could be fed back to selectively shutter the UV laser or the active mask 1060. For example, the illuminating laser might be scanned across the area being ablated through the mask array 1060, illuminating in sequence each area corresponding to the projected image of one of the elements of the mask array. Scattered light detected by photodetector 1070 could then provide the feedback signal 1075 to shutter the laser beam selectively at the locations of the mask array that project to the areas of skin that have been ablated to the desired depth. By way of example only, it is known that at 330 nm-400 nm and 650-700 nm, melanin is highly absorptive while dermal absorption is negligible. The photodetector would be selected to transmit its control signal in response to an increase (or decrease) in remittance for the wavelength of an illuminating laser emitting light in one of these spectral regions.
  • Melanin, which is the pigment that colours the epidermis, originates from melanocytes in the basal cell layer. Once the basal layer is removed, a new basal layer must be regenerated in order to provide pigment to the overlying epidermis. If the skin is removed to such a depth that the hair follicles included in the region of removal are too badly damaged, they will fail to act as "seeds" for regeneration of a pigmented basal layer, and the healed region will appear to be much whiter (contain less melanin) than the surrounding skin. The UV Dermablation method and apparatus of the present invention advantageously provides such fine depth control that the hair follicles will be spared from destruction, remaining viable and capable of acting as a source for regeneration of a fully functional basal layer, including fresh melanocytes capable of providing a pigmentation that matches the surrounding skin.
  • In the application of UV Dermablation to remove basal cell carcinomas, the skin to be treated can be first stained by an exogenous agent, a chemical such as those used for histological preparation of biopsy specimens. This will "mark" the lesion with a coloration and darkness that will provide contrast to surrounding healthy tissue. Then the scheme of Fig. 9 can be used to control the dermablation process, with a visible laser beam illuminating the tissue at the point of ablation, the scattered visible light being measured to determine if that point has lesion tissue or healthy tissue at the surface, and this measurement being used to control the shuttering of the uv beam when healthy tissue is at the point of irradiation. A scan can be taken over a designated area containing the basal cell carcinoma, and this scan can be repeated for a sufficient number of iterations until the lesion is entirely removed, as determined by the measurement signal derived from the scattered visible light.

Claims (9)

  1. A surgical system for removing skin, comprising:
    a pulsed light source (400, 415, 402, 550, 660, 700, 810, 950, 1110) capable of delivering a fluence F exceeding an ablation threshold fluence F th ; and
    a control mechanism, coupled to the light source, for directing light from the light source to locations on the skin and determining if a skin location has been ablated to a desired depth;
    characterised in that the pulsed light source (810) is an ArF laser and in that it further comprises
    a coagulating light source (820) having a different wavelength than the ArF laser ;
    means for detecting the appearance of blood at a given skin location; and
    means for switching to the coagulating light source, in response to the detection of blood at a given skin location.
  2. A surgical system as claimed in claim 1 wherein the control mechanism comprises means for controllably ablating the epidermis along the contours of an epidermal/dermal boundary.
  3. A surgical system as claimed in claim 2 wherein said means for controllably ablating further comprises means for detecting a colour change near or at the epidermal/dermal boundary.
  4. A surgical system as claimed in claim 1, wherein the control mechanism further comprises:
    one or more rotatable mirrors (215, 420), the mirrors positioned in the light source path for controllably scanning the light source (415);
    one or more motors, coupled to the mirrors, for angularly rotating and feeding back angular positions of the one or more mirrors; and
    a computer (425), coupled to the light source and the motors for controlling the motors and selectively shuttering the light source at a given location on the skin.
  5. A surgical system as claimed in claim 4 wherein the mirrors (215, 420) comprise at least two mirrors having axes at right angles to one another.
  6. A surgical system as claimed in claim 1, comprising:
    an active mask array (1060), coupled to the mechanism control for selectively shuttering the light source at a given location that has been ablated to the desired depth.
  7. A surgical system as claimed in claim 1 wherein the system comprises a robot/laser system, further comprising:
    a camera (515, 630, 735) for visualizing an image of the locations on the skin;
    a computer (525, 740), coupled to the camera, the computer having an output for displaying and an input for designating the locations of the skin to which the laser is directed.
  8. A surgical system as claimed in claim 1 wherein the system further comprises a mechanism for focusing the laser beam to a small spot approximately ∼25 µm in diameter.
  9. A surgical system as claimed in claim 1, wherein the control mechanism includes an alignment mechanism, comprising:
    a visible laser (412), said laser emitting a beam illuminating the skin at a location coincident with the ablating light;
    means for scanning the beam across the locations on the skin; and
    means for recording scanned beam positions, coupled to said means for scanning, for subsequent automatic scan of an ablating light source across the locations (407) on the skin.
EP99300177A 1998-01-29 1999-01-12 Laser for dermal ablation Expired - Lifetime EP0933096B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15875 1998-01-29
US09/015,875 US6165170A (en) 1998-01-29 1998-01-29 Laser dermablator and dermablation

Publications (3)

Publication Number Publication Date
EP0933096A2 EP0933096A2 (en) 1999-08-04
EP0933096A3 EP0933096A3 (en) 1999-11-03
EP0933096B1 true EP0933096B1 (en) 2008-01-02

Family

ID=21774128

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99300177A Expired - Lifetime EP0933096B1 (en) 1998-01-29 1999-01-12 Laser for dermal ablation

Country Status (9)

Country Link
US (2) US6165170A (en)
EP (1) EP0933096B1 (en)
JP (1) JP3229280B2 (en)
KR (1) KR100454522B1 (en)
CN (1) CN1145460C (en)
DE (1) DE69937850T2 (en)
HK (1) HK1021499A1 (en)
SG (1) SG114454A1 (en)
TW (1) TW403667B (en)

Cited By (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7724786B2 (en) 2003-06-06 2010-05-25 The General Hospital Corporation Process and apparatus for a wavelength tuning source
US7733497B2 (en) 2003-10-27 2010-06-08 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US7742173B2 (en) 2006-04-05 2010-06-22 The General Hospital Corporation Methods, arrangements and systems for polarization-sensitive optical frequency domain imaging of a sample
US7782464B2 (en) 2006-05-12 2010-08-24 The General Hospital Corporation Processes, arrangements and systems for providing a fiber layer thickness map based on optical coherence tomography images
US7796270B2 (en) 2006-01-10 2010-09-14 The General Hospital Corporation Systems and methods for generating data based on one or more spectrally-encoded endoscopy techniques
US7797119B2 (en) 2002-01-24 2010-09-14 The General Hospital Corporation Apparatus and method for rangings and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
US7809225B2 (en) 2004-07-02 2010-10-05 The General Hospital Corporation Imaging system and related techniques
US7843572B2 (en) 2005-09-29 2010-11-30 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US7859679B2 (en) 2005-05-31 2010-12-28 The General Hospital Corporation System, method and arrangement which can use spectral encoding heterodyne interferometry techniques for imaging
US7889348B2 (en) 2005-10-14 2011-02-15 The General Hospital Corporation Arrangements and methods for facilitating photoluminescence imaging
US7920271B2 (en) 2006-08-25 2011-04-05 The General Hospital Corporation Apparatus and methods for enhancing optical coherence tomography imaging using volumetric filtering techniques
US7933021B2 (en) 2007-10-30 2011-04-26 The General Hospital Corporation System and method for cladding mode detection
US7949019B2 (en) 2007-01-19 2011-05-24 The General Hospital Wavelength tuning source based on a rotatable reflector
US7982879B2 (en) 2006-02-24 2011-07-19 The General Hospital Corporation Methods and systems for performing angle-resolved fourier-domain optical coherence tomography
US7995210B2 (en) 2004-11-24 2011-08-09 The General Hospital Corporation Devices and arrangements for performing coherence range imaging using a common path interferometer
US8018598B2 (en) 2004-05-29 2011-09-13 The General Hospital Corporation Process, system and software arrangement for a chromatic dispersion compensation using reflective layers in optical coherence tomography (OCT) imaging
US8040608B2 (en) 2007-08-31 2011-10-18 The General Hospital Corporation System and method for self-interference fluorescence microscopy, and computer-accessible medium associated therewith
US8050747B2 (en) 2001-05-01 2011-11-01 The General Hospital Corporation Method and apparatus for determination of atherosclerotic plaque type by measurement of tissue optical properties
US8054468B2 (en) 2003-01-24 2011-11-08 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
US8081316B2 (en) 2004-08-06 2011-12-20 The General Hospital Corporation Process, system and software arrangement for determining at least one location in a sample using an optical coherence tomography
US8097864B2 (en) 2009-01-26 2012-01-17 The General Hospital Corporation System, method and computer-accessible medium for providing wide-field superresolution microscopy
US8115919B2 (en) 2007-05-04 2012-02-14 The General Hospital Corporation Methods, arrangements and systems for obtaining information associated with a sample using optical microscopy
US8145018B2 (en) 2006-01-19 2012-03-27 The General Hospital Corporation Apparatus for obtaining information for a structure using spectrally-encoded endoscopy techniques and methods for producing one or more optical arrangements
US8175685B2 (en) 2006-05-10 2012-05-08 The General Hospital Corporation Process, arrangements and systems for providing frequency domain imaging of a sample
US8174702B2 (en) 2003-01-24 2012-05-08 The General Hospital Corporation Speckle reduction in optical coherence tomography by path length encoded angular compounding
US8208995B2 (en) 2004-08-24 2012-06-26 The General Hospital Corporation Method and apparatus for imaging of vessel segments
US8246611B2 (en) 2006-06-14 2012-08-21 Candela Corporation Treatment of skin by spatial modulation of thermal heating
USRE43875E1 (en) 2004-09-29 2012-12-25 The General Hospital Corporation System and method for optical coherence imaging
US8351665B2 (en) 2005-04-28 2013-01-08 The General Hospital Corporation Systems, processes and software arrangements for evaluating information associated with an anatomical structure by an optical coherence ranging technique
US8593619B2 (en) 2008-05-07 2013-11-26 The General Hospital Corporation System, method and computer-accessible medium for tracking vessel motion during three-dimensional coronary artery microscopy
US8721077B2 (en) 2011-04-29 2014-05-13 The General Hospital Corporation Systems, methods and computer-readable medium for determining depth-resolved physical and/or optical properties of scattering media by analyzing measured data over a range of depths
US8804126B2 (en) 2010-03-05 2014-08-12 The General Hospital Corporation Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution
US8838213B2 (en) 2006-10-19 2014-09-16 The General Hospital Corporation Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s)
US8861910B2 (en) 2008-06-20 2014-10-14 The General Hospital Corporation Fused fiber optic coupler arrangement and method for use thereof
US8937724B2 (en) 2008-12-10 2015-01-20 The General Hospital Corporation Systems and methods for extending imaging depth range of optical coherence tomography through optical sub-sampling
US8965487B2 (en) 2004-08-24 2015-02-24 The General Hospital Corporation Process, system and software arrangement for measuring a mechanical strain and elastic properties of a sample
US9069130B2 (en) 2010-05-03 2015-06-30 The General Hospital Corporation Apparatus, method and system for generating optical radiation from biological gain media
US9087368B2 (en) 2006-01-19 2015-07-21 The General Hospital Corporation Methods and systems for optical imaging or epithelial luminal organs by beam scanning thereof
US9176319B2 (en) 2007-03-23 2015-11-03 The General Hospital Corporation Methods, arrangements and apparatus for utilizing a wavelength-swept laser using angular scanning and dispersion procedures
US9178330B2 (en) 2009-02-04 2015-11-03 The General Hospital Corporation Apparatus and method for utilization of a high-speed optical wavelength tuning source
US9186067B2 (en) 2006-02-01 2015-11-17 The General Hospital Corporation Apparatus for applying a plurality of electro-magnetic radiations to a sample
US9254089B2 (en) 2008-07-14 2016-02-09 The General Hospital Corporation Apparatus and methods for facilitating at least partial overlap of dispersed ration on at least one sample
US9330092B2 (en) 2011-07-19 2016-05-03 The General Hospital Corporation Systems, methods, apparatus and computer-accessible-medium for providing polarization-mode dispersion compensation in optical coherence tomography
US9332942B2 (en) 2008-01-28 2016-05-10 The General Hospital Corporation Systems, processes and computer-accessible medium for providing hybrid flourescence and optical coherence tomography imaging
US9341783B2 (en) 2011-10-18 2016-05-17 The General Hospital Corporation Apparatus and methods for producing and/or providing recirculating optical delay(s)
US9351642B2 (en) 2009-03-12 2016-05-31 The General Hospital Corporation Non-contact optical system, computer-accessible medium and method for measurement at least one mechanical property of tissue using coherent speckle technique(s)
US9375158B2 (en) 2007-07-31 2016-06-28 The General Hospital Corporation Systems and methods for providing beam scan patterns for high speed doppler optical frequency domain imaging
US9415550B2 (en) 2012-08-22 2016-08-16 The General Hospital Corporation System, method, and computer-accessible medium for fabrication miniature endoscope using soft lithography
US9441948B2 (en) 2005-08-09 2016-09-13 The General Hospital Corporation Apparatus, methods and storage medium for performing polarization-based quadrature demodulation in optical coherence tomography
US9510758B2 (en) 2010-10-27 2016-12-06 The General Hospital Corporation Apparatus, systems and methods for measuring blood pressure within at least one vessel
US9557154B2 (en) 2010-05-25 2017-01-31 The General Hospital Corporation Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions

Families Citing this family (280)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190376B1 (en) 1996-12-10 2001-02-20 Asah Medico A/S Apparatus for tissue treatment
WO2000053261A1 (en) 1999-03-08 2000-09-14 Asah Medico A/S An apparatus for tissue treatment and having a monitor for display of tissue features
US6074382A (en) 1997-08-29 2000-06-13 Asah Medico A/S Apparatus for tissue treatment
JP2002526128A (en) * 1998-07-09 2002-08-20 キュアライト・リミテッド High energy photodynamic therapy device and method effective for acne and seborrhea
US6059820A (en) 1998-10-16 2000-05-09 Paradigm Medical Corporation Tissue cooling rod for laser surgery
US6183773B1 (en) 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
US6936311B2 (en) * 1999-01-27 2005-08-30 The United States Of America As Represented By The Secretary Of The Navy Generation of biomaterial microarrays by laser transfer
US6905738B2 (en) * 1999-01-27 2005-06-14 The United States Of America As Represented By The Secretary Of The Navy Generation of viable cell active biomaterial patterns by laser transfer
CA2369792A1 (en) * 1999-04-27 2000-11-02 The General Hospital Corporation Phototherapy method for treatment of acne
US6413267B1 (en) * 1999-08-09 2002-07-02 Theralase, Inc. Therapeutic laser device and method including noninvasive subsurface monitoring and controlling means
JP3730454B2 (en) * 1999-09-21 2006-01-05 株式会社ニデック Laser equipment
KR100391004B1 (en) 1999-09-21 2003-07-12 가부시키가이샤 도요다 지도숏키 Method of producing a swash plate type compressor piston whose head portion is formed by pore-free die-casting
DE60045880D1 (en) 1999-09-24 2011-06-01 Nat Res Council Of Canada Ottawa Device for performing an intraoperative angiography
AU1085801A (en) * 1999-10-14 2001-04-23 Iridex Corporation Therapeutic use of long-pulse laser photocoagulation in combination with other treatment modalities
US6443976B1 (en) * 1999-11-30 2002-09-03 Akorn, Inc. Methods for treating conditions and illnesses associated with abnormal vasculature
US6502579B2 (en) * 2000-01-19 2003-01-07 William P. Young Laser onychectomy by resection of the redundant epithelium of the ungual crest
JP2004504074A (en) * 2000-02-22 2004-02-12 トールステンソン、ペル−アルヌ Method and apparatus for heat treatment of surface layer
DE10013910A1 (en) * 2000-03-21 2001-10-04 Vision Lasertechnik Fuer Forsc Method for removing hair using laser light in which an image capture and processing system is used to individually identify hairs and control and target a laser system that allows individual to be removed with a low power laser
JP2002011106A (en) * 2000-06-28 2002-01-15 Nidek Co Ltd Laser therapeutic apparatus
EP2269645A3 (en) * 2000-08-16 2011-01-12 The General Hospital Corporation doing business as Massachusetts General Hospital Topical aminolevulinic acid-photodynamic therapy for acne vulgaris
US6766187B1 (en) * 2000-09-18 2004-07-20 Lumenis Inc. Method for detecting coagulation in laser treatment of blood vessels
KR20020024830A (en) * 2000-09-27 2002-04-03 이용한 a laser medical appliance
WO2002032336A1 (en) * 2000-10-20 2002-04-25 Innovationsagentur Gesellschaft M.B.H. Method and device for controlling light sources for irradiating a body
DE10161175B4 (en) * 2000-12-18 2005-01-05 Thyssen Laser-Technik Gmbh Laser beam optics in a robot axis
KR20020060020A (en) * 2001-01-09 2002-07-16 박종윤 Medical Laser Instrument for Photodynamic Treatment or Photodynamic Diagnosis using High Power Semiconductor Laser Diode.
US8206379B2 (en) * 2001-02-02 2012-06-26 Homer Gregg S Techniques for alteration of iris pigment
US20040073199A1 (en) * 2001-02-02 2004-04-15 Homer Gregg S. Method for alteration of iris pigment
WO2002066550A1 (en) * 2001-02-20 2002-08-29 The United States Of America, As Represented By The Secretary Of The Navy Naval Research Laboratory Generation of biomaterial microarrays by laser transfer
US7947067B2 (en) * 2004-02-04 2011-05-24 Erchonia Corporation Scanning treatment laser with sweep beam spot and universal carriage
DE10115426C2 (en) * 2001-03-29 2003-03-13 W & H Dentalwerk Buermoos Ges Device and method for laser ablation of organic and inorganic material
DE10120787A1 (en) * 2001-04-25 2003-01-09 Foerderung Von Medizin Bio Und Remission-controlled device with laser handpiece for sensor-controlled selective laser therapy of blood vessels and skin tissues has multiple-sensor system e.g. using near infrared or visible radiation
GB0112503D0 (en) * 2001-05-23 2001-07-11 Tabatabaei Seyed D Apparatus and method for selectively irradiating a surface
US6736833B2 (en) * 2001-06-07 2004-05-18 Hospital For Special Surgery Application of UV to collagen for altering length and properties of tissue
CA2358756A1 (en) * 2001-10-09 2003-04-09 Robert S. Backstein Method and apparatus for treatment of skin
DE10152127B4 (en) * 2001-10-23 2004-09-30 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device for the controlled navigation of a medical instrument relative to human or animal tissue areas
GB2381752A (en) * 2001-11-06 2003-05-14 Ezio Panzeri Laser skin treatment device with control means dependent on a sensed property of the skin to be treated
US7935139B2 (en) * 2001-12-10 2011-05-03 Candela Corporation Eye safe dermatological phototherapy
US7762964B2 (en) * 2001-12-10 2010-07-27 Candela Corporation Method and apparatus for improving safety during exposure to a monochromatic light source
ES2287304T3 (en) * 2001-12-10 2007-12-16 Inolase 2002 Ltd. METHOD AND APPLIANCE FOR IMPROVING SECURITY DURING EXPOSURE TO A MONOCROMATIC LIGHT SOURCE.
EP1627662B1 (en) * 2004-06-10 2011-03-02 Candela Corporation Apparatus for vacuum-assisted light-based treatments of the skin
US7762965B2 (en) * 2001-12-10 2010-07-27 Candela Corporation Method and apparatus for vacuum-assisted light-based treatments of the skin
US20040082940A1 (en) * 2002-10-22 2004-04-29 Michael Black Dermatological apparatus and method
US6960201B2 (en) * 2002-02-11 2005-11-01 Quanticum, Llc Method for the prevention and treatment of skin and nail infections
US7494502B2 (en) 2002-02-11 2009-02-24 Keraderm, Llc Alteration of the skin and nail for the prevention and treatment of skin and nail infections
DE10220423B4 (en) * 2002-05-08 2005-02-24 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Device for the controlled navigation of a medical instrument relative to human or animal tissue areas
US20030228044A1 (en) * 2002-06-05 2003-12-11 Canon Kabushiki Kaisha Radiographic marker location
WO2004000098A2 (en) 2002-06-19 2003-12-31 Palomar Medical Technologies, Inc. Method and apparatus for treatment of cutaneous and subcutaneous conditions
AUPS313802A0 (en) * 2002-06-25 2002-07-18 Riancorp Pty Ltd Laser beam homogenisers in medical applications
US7740600B2 (en) * 2002-08-02 2010-06-22 Candela Corporation Apparatus and method for inhibiting pain signals transmitted during a skin related medical treatment
KR100508979B1 (en) * 2002-09-27 2005-08-17 주식회사 솔고 바이오메디칼 Erbium yag laser apparatus
US7458982B2 (en) * 2002-10-04 2008-12-02 Photokinetix, Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
US6916315B2 (en) * 2002-10-07 2005-07-12 Kenneth Lawrence Short Methods of operating a photo-thermal epilation apparatus
US20040091588A1 (en) * 2002-10-31 2004-05-13 Xiaochun Li Food processing apparatus and method
US7233817B2 (en) 2002-11-01 2007-06-19 Brian Yen Apparatus and method for pattern delivery of radiation and biological characteristic analysis
WO2004075976A2 (en) 2003-02-25 2004-09-10 Spectragenics, Inc. Method and apparatus for the treatment of benign pigmented lesions
EP2604215B1 (en) 2003-02-25 2017-10-11 Tria Beauty, Inc. Eye-safe dermatologic treatment apparatus and method
ES2570987T3 (en) 2003-02-25 2016-05-23 Tria Beauty Inc Dermatological treatment device, based on diode laser and autonomous
AU2004226378A1 (en) * 2003-03-27 2004-10-14 The General Hospital Corporation Method and apparatus for dermatological treatment and fractional skin resurfacing
US9655676B2 (en) 2003-05-16 2017-05-23 Trod Medical Method of percutaneous localized or focal treatment of prostate lesions using radio frequency
ATE426368T1 (en) * 2003-05-16 2009-04-15 Trod Medical MEDICAL DEVICE WITH A SPIRAL-SHAPED ELECTRODE
DE10332062A1 (en) * 2003-07-11 2005-01-27 Carl Zeiss Jena Gmbh Arrangement in the illumination beam path of a laser scanning microscope
JP4329431B2 (en) * 2003-07-14 2009-09-09 株式会社日立製作所 Position measuring device
CA2535475A1 (en) * 2003-10-14 2005-04-28 Gregg S. Homer Method and device for dermal retraction and collagen and elastin generation
US7282060B2 (en) 2003-12-23 2007-10-16 Reliant Technologies, Inc. Method and apparatus for monitoring and controlling laser-induced tissue treatment
US7507231B2 (en) * 2003-12-23 2009-03-24 Arthrex, Inc. Surgical power console with locking speed control
US7800014B2 (en) * 2004-01-09 2010-09-21 General Lasertronics Corporation Color sensing for laser decoating
US7633033B2 (en) 2004-01-09 2009-12-15 General Lasertronics Corporation Color sensing for laser decoating
US20050256553A1 (en) * 2004-02-09 2005-11-17 John Strisower Method and apparatus for the treatment of respiratory and other infections using ultraviolet germicidal irradiation
US8777935B2 (en) 2004-02-25 2014-07-15 Tria Beauty, Inc. Optical sensor and method for identifying the presence of skin
US7618415B2 (en) * 2004-04-09 2009-11-17 Technolas Perfect Vision Gmbh Beam steering system for corneal laser surgery
US9011329B2 (en) 2004-04-19 2015-04-21 Searete Llc Lumenally-active device
US8353896B2 (en) 2004-04-19 2013-01-15 The Invention Science Fund I, Llc Controllable release nasal system
US8512219B2 (en) 2004-04-19 2013-08-20 The Invention Science Fund I, Llc Bioelectromagnetic interface system
US7383768B2 (en) * 2004-05-05 2008-06-10 Awi Licensing Company Rapid prototyping and filling commercial pipeline
US7413572B2 (en) 2004-06-14 2008-08-19 Reliant Technologies, Inc. Adaptive control of optical pulses for laser medicine
US7635362B2 (en) * 2004-12-30 2009-12-22 Lutronic Corporation Method and apparatus treating area of the skin by using multipulse laser
DK1866627T3 (en) * 2005-01-31 2013-11-18 Edward S Neister METHOD AND APPARATUS FOR STERILIZING AND DISINFECTING AIR AND SURFACE AND PROTECTING A ZONE FROM EXTERNAL MICROBIAL POLLUTION
US11246951B2 (en) * 2005-01-31 2022-02-15 S. Edward Neister Method and apparatus for sterilizing and disinfecting air and surfaces and protecting a zone from external microbial contamination
DE102005010723A1 (en) * 2005-02-24 2006-08-31 LÜLLAU, Friedrich UV irradiation device for acting upon biological cellular structures, especially the skin, for medical and therapeutic purposes, has means for matching UV exposure geometries to those areas requiring treatment
US8157807B2 (en) * 2005-06-02 2012-04-17 The Invention Science Fund I, Llc Skin treatment including patterned light
EP1874389A1 (en) * 2005-04-18 2008-01-09 Pantec Biosolutions AG A system for transmembrane administration of a permeant
WO2006111201A1 (en) * 2005-04-18 2006-10-26 Pantec Biosolutions Ag Laser microporator
US7856985B2 (en) 2005-04-22 2010-12-28 Cynosure, Inc. Method of treatment body tissue using a non-uniform laser beam
US20060241696A1 (en) * 2005-04-26 2006-10-26 Stjepan Krco Method of limiting hair loss and promoting hair growth
US9055958B2 (en) 2005-06-29 2015-06-16 The Invention Science Fund I, Llc Hair modification using converging light
JP2009506835A (en) 2005-08-29 2009-02-19 リライアント・テクノロジーズ・インコーポレイテッド Method and apparatus for monitoring and controlling heat-induced tissue treatment
US20070049996A1 (en) * 2005-08-29 2007-03-01 Reliant Technologies, Inc. Monitoring Method and Apparatus for Fractional Photo-Therapy Treatment
AU2006295080A1 (en) * 2005-09-21 2007-04-05 Medtronic, Inc. Composite heart valve apparatus manufactured using techniques involving laser machining of tissue
WO2007064900A2 (en) * 2005-12-02 2007-06-07 Xoft, Inc. Treatment of lesions or imperfections in mammalian skin or near-skin tissues or in or near other anatomic surfaces
CN101404950B (en) * 2006-02-01 2015-08-19 通用医疗公司 For utilize conformal laser therapy procedures to monitor and obtain sample at least one part information and the method and system of electromagnetic radiation is provided at least one part of sample
WO2007143236A2 (en) * 2006-02-01 2007-12-13 The General Hospital Corporation Methods and systems for monitoring and obtaining information of at least one portion of a sample using conformal laser therapy procedures, and providing electromagnetic radiation thereto
EP1983921B1 (en) * 2006-02-01 2016-05-25 The General Hospital Corporation Systems for providing electromagnetic radiation to at least one portion of a sample using conformal laser therapy procedures
EP3143926B1 (en) 2006-02-08 2020-07-01 The General Hospital Corporation Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy
US8219178B2 (en) 2007-02-16 2012-07-10 Catholic Healthcare West Method and system for performing invasive medical procedures using a surgical robot
US10893912B2 (en) 2006-02-16 2021-01-19 Globus Medical Inc. Surgical tool systems and methods
US10357184B2 (en) 2012-06-21 2019-07-23 Globus Medical, Inc. Surgical tool systems and method
US10653497B2 (en) 2006-02-16 2020-05-19 Globus Medical, Inc. Surgical tool systems and methods
US20120035540A1 (en) 2006-04-12 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Event-based control of a lumen traveling device
US9220917B2 (en) 2006-04-12 2015-12-29 The Invention Science Fund I, Llc Systems for autofluorescent imaging and target ablation
WO2007129424A1 (en) * 2006-04-14 2007-11-15 Sumitomo Electric Industries, Ltd. Treatment device and treatment method
CN101478931B (en) * 2006-06-29 2012-09-19 皇家飞利浦电子股份有限公司 A surface detection system for use with a droplet spray oral cleaning device
US7586957B2 (en) 2006-08-02 2009-09-08 Cynosure, Inc Picosecond laser apparatus and methods for its operation and use
US9084622B2 (en) * 2006-08-02 2015-07-21 Omnitek Partners Llc Automated laser-treatment system with real-time integrated 3D vision system for laser debridement and the like
WO2008049903A2 (en) * 2006-10-25 2008-05-02 Pantec Biosolutions Ag Wide-area parasystemic treatment of skin related conditions
US20080208179A1 (en) * 2006-10-26 2008-08-28 Reliant Technologies, Inc. Methods of increasing skin permeability by treatment with electromagnetic radiation
MX2009005400A (en) * 2006-11-29 2009-06-05 Genentech Inc Method of diagnosing and treating glioma.
US20080208295A1 (en) * 2007-02-28 2008-08-28 Cumbie William E Phototherapy Treatment and Device to Improve the Appearance of Nails and skin
ES2636973T3 (en) 2007-03-02 2017-10-10 Candela Corporation Variable depth skin heating with lasers
US8536483B2 (en) 2007-03-22 2013-09-17 General Lasertronics Corporation Methods for stripping and modifying surfaces with laser-induced ablation
WO2008121844A1 (en) 2007-03-30 2008-10-09 The General Hospital Corporation System and method providing intracoronary laser speckle imaging for the detection of vulnerable plaque
KR20100029235A (en) * 2007-06-08 2010-03-16 싸이노슈어, 인코포레이티드 Surgical waveguide
AT505356B1 (en) * 2007-06-13 2009-04-15 Lechthaler Andreas DEVICE FOR IRRADIATING AN OBJECT, IN PARTICULAR THE HUMAN SKIN, WITH UV LIGHT
ES2454974T3 (en) 2007-06-27 2014-04-14 The General Hospital Corporation Apparatus for optical inhibition of photodynamic therapy
DE602007009518D1 (en) 2007-07-28 2010-11-11 Fotona D D Laser system for medical removal of body tissue
EP2194899A4 (en) 2007-08-08 2012-11-28 Tria Beauty Inc Capacitive sensing method and device for detecting skin
EP2030586B1 (en) * 2007-09-01 2011-05-11 Fotona d.d. Laser system for medical and cosmetic applications
EP2197382A4 (en) * 2007-09-10 2013-01-23 Alcon Lensx Inc Effective laser photodisruptive surgery in a gravity field
US7740651B2 (en) * 2007-09-28 2010-06-22 Candela Corporation Vacuum assisted treatment of the skin
WO2009052866A1 (en) * 2007-10-25 2009-04-30 Pantec Biosolutions Ag Laser device and method for ablating biological tissue
US11123047B2 (en) 2008-01-28 2021-09-21 The General Hospital Corporation Hybrid systems and methods for multi-modal acquisition of intravascular imaging data and counteracting the effects of signal absorption in blood
JP5404762B2 (en) * 2008-03-21 2014-02-05 コーニンクレッカ フィリップス エヌ ヴェ Hair removal system and method
EP2268198A4 (en) 2008-04-25 2014-10-15 Tria Beauty Inc Optical sensor and method for identifying the presence of skin and the pigmentation of skin
US20090275928A1 (en) * 2008-05-01 2009-11-05 Solomon Mark P Suture-less laser blepharoplasty with skin tightening
EP2320822A4 (en) * 2008-07-28 2011-11-16 Xintec Corp Multi-wavelength laser and method for contact ablation of tissue
WO2010022330A2 (en) * 2008-08-21 2010-02-25 University Of Florida Research Foundation, Inc. Differential laser-induced perturbation (dlip) for bioimaging and chemical sensing
DE102008048409A1 (en) * 2008-09-23 2010-03-25 Megasun Invest Ag Method and device for hair removal
KR101135610B1 (en) * 2008-10-13 2012-04-17 한국과학기술원 Laser Robot with Vision System
US8961450B2 (en) 2009-05-26 2015-02-24 The General Hospital Corporation Method and apparatus for dermal delivery of a substance
US8594383B2 (en) * 2009-05-27 2013-11-26 Hewlett-Packard Development Company, L.P. Method and apparatus for evaluating printed images
WO2011008822A2 (en) 2009-07-14 2011-01-20 The General Hospital Corporation Apparatus, systems and methods for measuring flow and pressure within a vessel
US20110051229A1 (en) * 2009-08-25 2011-03-03 StingRay Optics, LLC Achromatic visible to far infrared objective lens
EP2480153B1 (en) * 2009-09-22 2016-08-10 Advanced Osteotomy Tools - AOT AG Carlo-computer assisted and robot guided laser-osteotome
US20130046293A1 (en) * 2010-03-09 2013-02-21 Keio University System for preventing blood charring at laser beam emitting site of laser catheter
US20130190742A1 (en) * 2010-04-13 2013-07-25 International Business Machines Corporation System and method for modification and/or smoothing of tissue with laser ablation
EP2575598A2 (en) 2010-05-25 2013-04-10 The General Hospital Corporation Apparatus, systems, methods and computer-accessible medium for spectral analysis of optical coherence tomography images
WO2011153434A2 (en) 2010-06-03 2011-12-08 The General Hospital Corporation Apparatus and method for devices for imaging structures in or at one or more luminal organs
US10112257B1 (en) 2010-07-09 2018-10-30 General Lasertronics Corporation Coating ablating apparatus with coating removal detection
WO2012131660A1 (en) 2011-04-01 2012-10-04 Ecole Polytechnique Federale De Lausanne (Epfl) Robotic system for spinal and other surgeries
US8936366B2 (en) 2011-06-17 2015-01-20 Microsoft Corporation Illuminated skin robot display
DE102011052002B4 (en) * 2011-07-20 2013-04-11 Telesto GmbH Laser therapy system with UVA and IR laser light for the directed generation of a dermal collagen matrix
WO2013029047A1 (en) 2011-08-25 2013-02-28 The General Hospital Corporation Methods, systems, arrangements and computer-accessible medium for providing micro-optical coherence tomography procedures
KR20130095555A (en) * 2012-02-20 2013-08-28 삼성전자주식회사 Lighting optics
US9895771B2 (en) 2012-02-28 2018-02-20 General Lasertronics Corporation Laser ablation for the environmentally beneficial removal of surface coatings
US9788730B2 (en) * 2012-03-08 2017-10-17 Dermasensor, Inc. Optical process and apparatus for non-invasive detection of melanoma
WO2013148306A1 (en) 2012-03-30 2013-10-03 The General Hospital Corporation Imaging system, method and distal attachment for multidirectional field of view endoscopy
EP2839552A4 (en) 2012-04-18 2015-12-30 Cynosure Inc Picosecond laser apparatus and methods for treating target tissues with same
EP2852315A4 (en) 2012-05-21 2016-06-08 Gen Hospital Corp Apparatus, device and method for capsule microscopy
US11395706B2 (en) 2012-06-21 2022-07-26 Globus Medical Inc. Surgical robot platform
US11864839B2 (en) 2012-06-21 2024-01-09 Globus Medical Inc. Methods of adjusting a virtual implant and related surgical navigation systems
US11607149B2 (en) 2012-06-21 2023-03-21 Globus Medical Inc. Surgical tool systems and method
US11793570B2 (en) 2012-06-21 2023-10-24 Globus Medical Inc. Surgical robotic automation with tracking markers
US11864745B2 (en) 2012-06-21 2024-01-09 Globus Medical, Inc. Surgical robotic system with retractor
US10624710B2 (en) 2012-06-21 2020-04-21 Globus Medical, Inc. System and method for measuring depth of instrumentation
US10758315B2 (en) 2012-06-21 2020-09-01 Globus Medical Inc. Method and system for improving 2D-3D registration convergence
US10231791B2 (en) 2012-06-21 2019-03-19 Globus Medical, Inc. Infrared signal based position recognition system for use with a robot-assisted surgery
US11253327B2 (en) 2012-06-21 2022-02-22 Globus Medical, Inc. Systems and methods for automatically changing an end-effector on a surgical robot
US11857266B2 (en) 2012-06-21 2024-01-02 Globus Medical, Inc. System for a surveillance marker in robotic-assisted surgery
US11298196B2 (en) 2012-06-21 2022-04-12 Globus Medical Inc. Surgical robotic automation with tracking markers and controlled tool advancement
US10350013B2 (en) 2012-06-21 2019-07-16 Globus Medical, Inc. Surgical tool systems and methods
US11116576B2 (en) 2012-06-21 2021-09-14 Globus Medical Inc. Dynamic reference arrays and methods of use
EP2863827B1 (en) 2012-06-21 2022-11-16 Globus Medical, Inc. Surgical robot platform
US11857149B2 (en) 2012-06-21 2024-01-02 Globus Medical, Inc. Surgical robotic systems with target trajectory deviation monitoring and related methods
US11045267B2 (en) 2012-06-21 2021-06-29 Globus Medical, Inc. Surgical robotic automation with tracking markers
US11317971B2 (en) 2012-06-21 2022-05-03 Globus Medical, Inc. Systems and methods related to robotic guidance in surgery
US11399900B2 (en) 2012-06-21 2022-08-02 Globus Medical, Inc. Robotic systems providing co-registration using natural fiducials and related methods
US10136954B2 (en) 2012-06-21 2018-11-27 Globus Medical, Inc. Surgical tool systems and method
US10463361B2 (en) * 2012-07-13 2019-11-05 The University Of North Carolina At Charlotte Selective laser vaporization of materials
US10893806B2 (en) 2013-01-29 2021-01-19 The General Hospital Corporation Apparatus, systems and methods for providing information regarding the aortic valve
WO2014121082A1 (en) 2013-02-01 2014-08-07 The General Hospital Corporation Objective lens arrangement for confocal endomicroscopy
EP2967744B1 (en) * 2013-03-14 2017-10-18 Syneron Medical Ltd. Skin treatment apparatus
KR102341328B1 (en) * 2013-03-15 2021-12-21 앤마리 힙슬레이 Systems and methods for affecting the biomechanical properties of connective tissue
EP2967491B1 (en) 2013-03-15 2022-05-11 The General Hospital Corporation A transesophageal endoscopic system for determining a mixed venous oxygen saturation of a pulmonary artery
WO2014145707A2 (en) 2013-03-15 2014-09-18 Cynosure, Inc. Picosecond optical radiation systems and methods of use
WO2014174010A1 (en) * 2013-04-25 2014-10-30 Koninklijke Philips N.V. Non-invasive device for treatment of the skin using laser light
EP2997354A4 (en) 2013-05-13 2017-01-18 The General Hospital Corporation Detecting self-interefering fluorescence phase and amplitude
WO2015003103A1 (en) * 2013-07-02 2015-01-08 Pine Development Corporation Systems and methods for eliciting cutaneous sensations using electromagnetic radiation
US10413359B2 (en) 2013-07-18 2019-09-17 International Business Machines Corporation Laser-assisted transdermal delivery of nanoparticulates and hydrogels
US10117576B2 (en) 2013-07-19 2018-11-06 The General Hospital Corporation System, method and computer accessible medium for determining eye motion by imaging retina and providing feedback for acquisition of signals from the retina
EP3692887B1 (en) 2013-07-19 2024-03-06 The General Hospital Corporation Imaging apparatus which utilizes multidirectional field of view endoscopy
WO2015013651A2 (en) 2013-07-26 2015-01-29 The General Hospital Corporation System, apparatus and method utilizing optical dispersion for fourier-domain optical coherence tomography
CA2920858A1 (en) * 2013-08-09 2015-02-12 The General Hospital Corporation Method and apparatus for treating dermal melasma
US9283048B2 (en) 2013-10-04 2016-03-15 KB Medical SA Apparatus and systems for precise guidance of surgical tools
US9282985B2 (en) * 2013-11-11 2016-03-15 Gyrus Acmi, Inc. Aiming beam detection for safe laser lithotripsy
WO2015105870A1 (en) 2014-01-08 2015-07-16 The General Hospital Corporation Method and apparatus for microscopic imaging
WO2015107099A1 (en) 2014-01-15 2015-07-23 KB Medical SA Notched apparatus for guidance of an insertable instrument along an axis during spinal surgery
US10086597B2 (en) 2014-01-21 2018-10-02 General Lasertronics Corporation Laser film debonding method
US10736494B2 (en) 2014-01-31 2020-08-11 The General Hospital Corporation System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device
WO2015114631A1 (en) * 2014-02-01 2015-08-06 Shimon Mizrahi Detecting and treating skin surface features
US10039605B2 (en) 2014-02-11 2018-08-07 Globus Medical, Inc. Sterile handle for controlling a robotic surgical system from a sterile field
KR101437540B1 (en) * 2014-03-31 2014-09-05 (주)라메디텍 Multi-function laser irradiating apparatus
US11559353B1 (en) * 2014-04-01 2023-01-24 Gregg S. Homer Ablative skin resurfacing with topical radiation block
WO2015153982A1 (en) 2014-04-04 2015-10-08 The General Hospital Corporation Apparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s)
US10004562B2 (en) 2014-04-24 2018-06-26 Globus Medical, Inc. Surgical instrument holder for use with a robotic surgical system
US9254075B2 (en) 2014-05-04 2016-02-09 Gyrus Acmi, Inc. Location of fragments during lithotripsy
US10420608B2 (en) * 2014-05-20 2019-09-24 Verily Life Sciences Llc System for laser ablation surgery
WO2016004275A1 (en) * 2014-07-03 2016-01-07 Northeastern University Melanin ablation guided by stepwise multi-photon activated fluorescence
US10357257B2 (en) 2014-07-14 2019-07-23 KB Medical SA Anti-skid surgical instrument for use in preparing holes in bone tissue
WO2016015052A1 (en) 2014-07-25 2016-01-28 The General Hospital Corporation Apparatus, devices and methods for in vivo imaging and diagnosis
US10013808B2 (en) 2015-02-03 2018-07-03 Globus Medical, Inc. Surgeon head-mounted display apparatuses
WO2016131903A1 (en) 2015-02-18 2016-08-25 KB Medical SA Systems and methods for performing minimally invasive spinal surgery with a robotic surgical system using a percutaneous technique
CA2977073A1 (en) * 2015-02-23 2016-09-01 Li-Cor, Inc. Fluorescence biopsy specimen imager and methods
GB2536650A (en) 2015-03-24 2016-09-28 Augmedics Ltd Method and system for combining video-based and optic-based augmented reality in a near eye display
EP3314234B1 (en) 2015-06-26 2021-05-19 Li-Cor, Inc. Fluorescence biopsy specimen imager
US10058394B2 (en) 2015-07-31 2018-08-28 Globus Medical, Inc. Robot arm and methods of use
US10646298B2 (en) 2015-07-31 2020-05-12 Globus Medical, Inc. Robot arm and methods of use
US10080615B2 (en) 2015-08-12 2018-09-25 Globus Medical, Inc. Devices and methods for temporary mounting of parts to bone
WO2017037127A1 (en) 2015-08-31 2017-03-09 KB Medical SA Robotic surgical systems and methods
DE102015216891A1 (en) * 2015-09-03 2017-03-09 Vimecon Gmbh Ablation catheter with sensors for recording ablation success
US10034716B2 (en) 2015-09-14 2018-07-31 Globus Medical, Inc. Surgical robotic systems and methods thereof
US9771092B2 (en) 2015-10-13 2017-09-26 Globus Medical, Inc. Stabilizer wheel assembly and methods of use
FI20155784A (en) 2015-11-02 2017-05-03 Cryotech Nordic Oü Automated system for laser-assisted dermatological treatment and control procedure
FR3046546B1 (en) * 2016-01-07 2020-12-25 Urgo Rech Innovation Et Developpement DERMATOLOGICAL TREATMENT DEVICE
US10448910B2 (en) 2016-02-03 2019-10-22 Globus Medical, Inc. Portable medical imaging system
US11883217B2 (en) 2016-02-03 2024-01-30 Globus Medical, Inc. Portable medical imaging system and method
US11058378B2 (en) 2016-02-03 2021-07-13 Globus Medical, Inc. Portable medical imaging system
US10842453B2 (en) 2016-02-03 2020-11-24 Globus Medical, Inc. Portable medical imaging system
US10117632B2 (en) 2016-02-03 2018-11-06 Globus Medical, Inc. Portable medical imaging system with beam scanning collimator
US10866119B2 (en) 2016-03-14 2020-12-15 Globus Medical, Inc. Metal detector for detecting insertion of a surgical device into a hollow tube
KR102594430B1 (en) 2016-04-19 2023-10-26 주식회사 레인보우로보틱스 Apparatus and Method For Laser Emitting using Robot-Arm
US10489964B2 (en) 2016-04-21 2019-11-26 Li-Cor, Inc. Multimodality multi-axis 3-D imaging with X-ray
WO2017223378A1 (en) 2016-06-23 2017-12-28 Li-Cor, Inc. Complementary color flashing for multichannel image presentation
US10993622B2 (en) 2016-11-23 2021-05-04 Li-Cor, Inc. Motion-adaptive interactive imaging method
EP3360502A3 (en) 2017-01-18 2018-10-31 KB Medical SA Robotic navigation of robotic surgical systems
US11071594B2 (en) 2017-03-16 2021-07-27 KB Medical SA Robotic navigation of robotic surgical systems
EP3616158A1 (en) 2017-04-25 2020-03-04 Li-Cor, Inc. Top-down and rotational side view biopsy specimen imager and methods
US11135015B2 (en) 2017-07-21 2021-10-05 Globus Medical, Inc. Robot surgical platform
US11357548B2 (en) 2017-11-09 2022-06-14 Globus Medical, Inc. Robotic rod benders and related mechanical and motor housings
EP3492032B1 (en) 2017-11-09 2023-01-04 Globus Medical, Inc. Surgical robotic systems for bending surgical rods
US11794338B2 (en) 2017-11-09 2023-10-24 Globus Medical Inc. Robotic rod benders and related mechanical and motor housings
US11134862B2 (en) 2017-11-10 2021-10-05 Globus Medical, Inc. Methods of selecting surgical implants and related devices
US20190254753A1 (en) 2018-02-19 2019-08-22 Globus Medical, Inc. Augmented reality navigation systems for use with robotic surgical systems and methods of their use
CA3092248A1 (en) 2018-02-26 2019-08-29 Mirko Mirkov Q-switched cavity dumped sub-nanosecond laser
US10573023B2 (en) 2018-04-09 2020-02-25 Globus Medical, Inc. Predictive visualization of medical imaging scanner component movement
TWI714859B (en) * 2018-06-13 2021-01-01 睿新醫電股份有限公司 Wearable laser soothing aid
KR20210022705A (en) 2018-06-22 2021-03-03 아바바, 인코포레이티드 Detecting feedback on the treatment device
US11439462B2 (en) 2018-10-16 2022-09-13 Simon Ourian System and method for laser skin resurfacing
US11897127B2 (en) * 2018-10-22 2024-02-13 Intuitive Surgical Operations, Inc. Systems and methods for master/tool registration and control for intuitive motion
US11337742B2 (en) 2018-11-05 2022-05-24 Globus Medical Inc Compliant orthopedic driver
US11278360B2 (en) 2018-11-16 2022-03-22 Globus Medical, Inc. End-effectors for surgical robotic systems having sealed optical components
US11766296B2 (en) 2018-11-26 2023-09-26 Augmedics Ltd. Tracking system for image-guided surgery
US11744655B2 (en) 2018-12-04 2023-09-05 Globus Medical, Inc. Drill guide fixtures, cranial insertion fixtures, and related methods and robotic systems
US11602402B2 (en) 2018-12-04 2023-03-14 Globus Medical, Inc. Drill guide fixtures, cranial insertion fixtures, and related methods and robotic systems
CN111578908A (en) 2019-02-15 2020-08-25 维蒂克影像国际无限责任公司 Method for detecting the correct orientation of a decal on a material
US11317978B2 (en) 2019-03-22 2022-05-03 Globus Medical, Inc. System for neuronavigation registration and robotic trajectory guidance, robotic surgery, and related methods and devices
US11571265B2 (en) 2019-03-22 2023-02-07 Globus Medical Inc. System for neuronavigation registration and robotic trajectory guidance, robotic surgery, and related methods and devices
US11419616B2 (en) 2019-03-22 2022-08-23 Globus Medical, Inc. System for neuronavigation registration and robotic trajectory guidance, robotic surgery, and related methods and devices
US11382549B2 (en) 2019-03-22 2022-07-12 Globus Medical, Inc. System for neuronavigation registration and robotic trajectory guidance, and related methods and devices
US11806084B2 (en) 2019-03-22 2023-11-07 Globus Medical, Inc. System for neuronavigation registration and robotic trajectory guidance, and related methods and devices
US10667855B1 (en) 2019-05-10 2020-06-02 Trod Medical Us, Llc Dual coil ablation devices
US11045179B2 (en) 2019-05-20 2021-06-29 Global Medical Inc Robot-mounted retractor system
US11628023B2 (en) 2019-07-10 2023-04-18 Globus Medical, Inc. Robotic navigational system for interbody implants
US11571171B2 (en) 2019-09-24 2023-02-07 Globus Medical, Inc. Compound curve cable chain
US11864857B2 (en) 2019-09-27 2024-01-09 Globus Medical, Inc. Surgical robot with passive end effector
US11890066B2 (en) 2019-09-30 2024-02-06 Globus Medical, Inc Surgical robot with passive end effector
US11426178B2 (en) 2019-09-27 2022-08-30 Globus Medical Inc. Systems and methods for navigating a pin guide driver
EP4041162A4 (en) * 2019-10-11 2023-12-13 Becc Applied Sciences, L.L.C. In situ promotion of cellular structure by selective application of electro-magnetic waves
US11510684B2 (en) 2019-10-14 2022-11-29 Globus Medical, Inc. Rotary motion passive end effector for surgical robots in orthopedic surgeries
US11382712B2 (en) 2019-12-22 2022-07-12 Augmedics Ltd. Mirroring in image guided surgery
US11382699B2 (en) 2020-02-10 2022-07-12 Globus Medical Inc. Extended reality visualization of optical tool tracking volume for computer assisted navigation in surgery
US11207150B2 (en) 2020-02-19 2021-12-28 Globus Medical, Inc. Displaying a virtual model of a planned instrument attachment to ensure correct selection of physical instrument attachment
US11253216B2 (en) 2020-04-28 2022-02-22 Globus Medical Inc. Fixtures for fluoroscopic imaging systems and related navigation systems and methods
US11153555B1 (en) 2020-05-08 2021-10-19 Globus Medical Inc. Extended reality headset camera system for computer assisted navigation in surgery
US11382700B2 (en) 2020-05-08 2022-07-12 Globus Medical Inc. Extended reality headset tool tracking and control
US11510750B2 (en) 2020-05-08 2022-11-29 Globus Medical, Inc. Leveraging two-dimensional digital imaging and communication in medicine imagery in three-dimensional extended reality applications
US11317973B2 (en) 2020-06-09 2022-05-03 Globus Medical, Inc. Camera tracking bar for computer assisted navigation during surgery
US11382713B2 (en) 2020-06-16 2022-07-12 Globus Medical, Inc. Navigated surgical system with eye to XR headset display calibration
US11877807B2 (en) 2020-07-10 2024-01-23 Globus Medical, Inc Instruments for navigated orthopedic surgeries
US11793588B2 (en) 2020-07-23 2023-10-24 Globus Medical, Inc. Sterile draping of robotic arms
CN111803208B (en) * 2020-08-04 2022-08-19 吉林省科英激光股份有限公司 Laser scanning control system suitable for microsurgery adapter
US11737831B2 (en) 2020-09-02 2023-08-29 Globus Medical Inc. Surgical object tracking template generation for computer assisted navigation during surgical procedure
US11523785B2 (en) 2020-09-24 2022-12-13 Globus Medical, Inc. Increased cone beam computed tomography volume length without requiring stitching or longitudinal C-arm movement
US11911112B2 (en) 2020-10-27 2024-02-27 Globus Medical, Inc. Robotic navigational system
US11717350B2 (en) 2020-11-24 2023-08-08 Globus Medical Inc. Methods for robotic assistance and navigation in spinal surgery and related systems
US11857273B2 (en) 2021-07-06 2024-01-02 Globus Medical, Inc. Ultrasonic robotic surgical navigation
US11896445B2 (en) 2021-07-07 2024-02-13 Augmedics Ltd. Iliac pin and adapter
US11439444B1 (en) 2021-07-22 2022-09-13 Globus Medical, Inc. Screw tower and rod reduction tool
WO2023026229A1 (en) * 2021-08-26 2023-03-02 Augmedics Ltd. Registration and registration validation in image-guided surgery
US11911115B2 (en) 2021-12-20 2024-02-27 Globus Medical Inc. Flat panel registration fixture and method of using same
CN114832228A (en) * 2022-07-04 2022-08-02 中国科学院长春光学精密机械与物理研究所 Multi-wavelength laser promotes transdermal device of dosing
CN115944383B (en) * 2023-03-13 2023-06-13 武汉诺伊激光科技有限公司 Optical coupling device for laser medical treatment

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011324A1 (en) * 1997-08-29 1999-03-11 Asah Medico A/S An apparatus for tissue treatment

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3902036A (en) * 1974-05-02 1975-08-26 Western Electric Co Control system using multiplexed laser beams
US4215694A (en) * 1978-06-01 1980-08-05 Isakov Viktor L Laser therapy apparatus
US4420812A (en) * 1979-09-14 1983-12-13 Tokico, Ltd. Teaching- playback robot
US4316467A (en) * 1980-06-23 1982-02-23 Lorenzo P. Maun Control for laser hemangioma treatment system
SE436848B (en) * 1982-06-28 1985-01-28 Asea Ab INDUSTRIROBOT CONTROL SYSTEM
EP0111060B1 (en) * 1982-12-09 1987-08-19 International Business Machines Corporation Ablative photodecomposition of organic biological material
US4784135A (en) * 1982-12-09 1988-11-15 International Business Machines Corporation Far ultraviolet surgical and dental procedures
US5409479A (en) * 1983-10-06 1995-04-25 Premier Laser Systems, Inc. Method for closing tissue wounds using radiative energy beams
US5108388B1 (en) * 1983-12-15 2000-09-19 Visx Inc Laser surgery method
CA1262757A (en) * 1985-04-25 1989-11-07 Richard M. Dwyer Method and apparatus for laser surgery
JPS6238413A (en) * 1985-08-13 1987-02-19 Toshiba Corp Optical scanning mechanism
US4791927A (en) * 1985-12-26 1988-12-20 Allied Corporation Dual-wavelength laser scalpel background of the invention
US5336217A (en) * 1986-04-24 1994-08-09 Institut National De La Sante Et De La Recherche Medicale (Insepm) Process for treatment by irradiating an area of a body, and treatment apparatus usable in dermatology for the treatment of cutaneous angio dysplasias
DE3831141A1 (en) * 1988-09-13 1990-03-22 Zeiss Carl Fa METHOD AND DEVICE FOR MICROSURGERY ON EYE BY LASER RADIATION
US5207576A (en) * 1989-04-07 1993-05-04 American Dental Laser, Inc. Dental laser assembly with dual lasers
US4973848A (en) * 1989-07-28 1990-11-27 J. Mccaughan Laser apparatus for concurrent analysis and treatment
DE4026240A1 (en) * 1990-08-18 1992-02-20 Koenig Hermann J Dr Med Removing tissue by pulsed focused laser radiation - applying far UV and/or IR range radiation esp for neurosurgery and continuously removing associated fluids
US5312396A (en) * 1990-09-06 1994-05-17 Massachusetts Institute Of Technology Pulsed laser system for the surgical removal of tissue
US5163933A (en) * 1990-10-22 1992-11-17 Cedars-Sinai Medical Center Prosthetic joint replacement procedure using excimer laser
JPH053927A (en) * 1991-06-28 1993-01-14 Topcon Corp Laser irradiation apparatus
JPH0515546A (en) * 1991-07-15 1993-01-26 Nidek Co Ltd Photocoagulator
US5217455A (en) * 1991-08-12 1993-06-08 Tan Oon T Laser treatment method for removing pigmentations, lesions, and abnormalities from the skin of a living human
US5532416A (en) * 1994-07-20 1996-07-02 Monsanto Company Benzoyl derivatives and synthesis thereof
US5423803A (en) * 1991-10-29 1995-06-13 Thermotrex Corporation Skin surface peeling process using laser
IL100664A0 (en) * 1992-01-15 1992-09-06 Laser Ind Ltd Method and apparatus for controlling a laser beam
US5405368A (en) * 1992-10-20 1995-04-11 Esc Inc. Method and apparatus for therapeutic electromagnetic treatment
US5643252A (en) * 1992-10-28 1997-07-01 Venisect, Inc. Laser perforator
US5527350A (en) * 1993-02-24 1996-06-18 Star Medical Technologies, Inc. Pulsed infrared laser treatment of psoriasis
CA2102884A1 (en) * 1993-03-04 1994-09-05 James J. Wynne Dental procedures and apparatus using ultraviolet radiation
US5387211B1 (en) * 1993-03-10 1996-12-31 Trimedyne Inc Multi-head laser assembly
JPH06277227A (en) * 1993-03-26 1994-10-04 Toshiba Medical Eng Co Ltd Laser medical treatment device
US5350376A (en) * 1993-04-16 1994-09-27 Ceramoptec, Inc. Optical controller device
US5860967A (en) * 1993-07-21 1999-01-19 Lucid, Inc. Dermatological laser treatment system with electronic visualization of the area being treated
IL108059A (en) * 1993-12-17 1998-02-22 Laser Ind Ltd Method and apparatus for applying laser beams to a working surface, particularly for ablating tissue
US5558666A (en) * 1994-01-14 1996-09-24 Coherent, Inc. Handpiece for producing highly collimated laser beam for dermatological procedures
JP2862202B2 (en) * 1994-04-28 1999-03-03 株式会社ニデック Corneal laser surgery device
US5554153A (en) * 1994-08-29 1996-09-10 Cell Robotics, Inc. Laser skin perforator
US5531740A (en) * 1994-09-06 1996-07-02 Rapistan Demag Corporation Automatic color-activated scanning treatment of dermatological conditions by laser
US5522813A (en) * 1994-09-23 1996-06-04 Coherent, Inc. Method of treating veins
US5571151A (en) * 1994-10-25 1996-11-05 Gregory; Kenton W. Method for contemporaneous application of laser energy and localized pharmacologic therapy
US5611795A (en) * 1995-02-03 1997-03-18 Laser Industries, Ltd. Laser facial rejuvenation
WO1996028212A1 (en) * 1995-03-09 1996-09-19 Innotech Usa, Inc. Laser surgical device and method of its use
DE19521003C1 (en) * 1995-06-08 1996-08-14 Baasel Carl Lasertech Pulsed light source for removing biological tissue
US5820627A (en) * 1996-03-28 1998-10-13 Physical Sciences, Inc. Real-time optical feedback control of laser lithotripsy
US5843072A (en) * 1996-11-07 1998-12-01 Cynosure, Inc. Method for treatment of unwanted veins and device therefor
US5655547A (en) * 1996-05-15 1997-08-12 Esc Medical Systems Ltd. Method for laser surgery
US6190376B1 (en) * 1996-12-10 2001-02-20 Asah Medico A/S Apparatus for tissue treatment
US6027496A (en) * 1997-03-25 2000-02-22 Abbott Laboratories Removal of stratum corneum by means of light

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011324A1 (en) * 1997-08-29 1999-03-11 Asah Medico A/S An apparatus for tissue treatment

Cited By (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8050747B2 (en) 2001-05-01 2011-11-01 The General Hospital Corporation Method and apparatus for determination of atherosclerotic plaque type by measurement of tissue optical properties
US8150496B2 (en) 2001-05-01 2012-04-03 The General Hospital Corporation Method and apparatus for determination of atherosclerotic plaque type by measurement of tissue optical properties
US7797119B2 (en) 2002-01-24 2010-09-14 The General Hospital Corporation Apparatus and method for rangings and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
US8559012B2 (en) 2003-01-24 2013-10-15 The General Hospital Corporation Speckle reduction in optical coherence tomography by path length encoded angular compounding
US8054468B2 (en) 2003-01-24 2011-11-08 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
US9226665B2 (en) 2003-01-24 2016-01-05 The General Hospital Corporation Speckle reduction in optical coherence tomography by path length encoded angular compounding
US8174702B2 (en) 2003-01-24 2012-05-08 The General Hospital Corporation Speckle reduction in optical coherence tomography by path length encoded angular compounding
US8416818B2 (en) 2003-06-06 2013-04-09 The General Hospital Corporation Process and apparatus for a wavelength tuning source
US7995627B2 (en) 2003-06-06 2011-08-09 The General Hospital Corporation Process and apparatus for a wavelength tuning source
US7724786B2 (en) 2003-06-06 2010-05-25 The General Hospital Corporation Process and apparatus for a wavelength tuning source
US8384909B2 (en) 2003-10-27 2013-02-26 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US8355138B2 (en) 2003-10-27 2013-01-15 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US8705046B2 (en) 2003-10-27 2014-04-22 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US9377290B2 (en) 2003-10-27 2016-06-28 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US7969578B2 (en) 2003-10-27 2011-06-28 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US7733497B2 (en) 2003-10-27 2010-06-08 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
US8018598B2 (en) 2004-05-29 2011-09-13 The General Hospital Corporation Process, system and software arrangement for a chromatic dispersion compensation using reflective layers in optical coherence tomography (OCT) imaging
US8676013B2 (en) 2004-07-02 2014-03-18 The General Hospital Corporation Imaging system using and related techniques
US7809225B2 (en) 2004-07-02 2010-10-05 The General Hospital Corporation Imaging system and related techniques
US8369669B2 (en) 2004-07-02 2013-02-05 The General Hospital Corporation Imaging system and related techniques
US9226660B2 (en) 2004-08-06 2016-01-05 The General Hospital Corporation Process, system and software arrangement for determining at least one location in a sample using an optical coherence tomography
US8081316B2 (en) 2004-08-06 2011-12-20 The General Hospital Corporation Process, system and software arrangement for determining at least one location in a sample using an optical coherence tomography
US9254102B2 (en) 2004-08-24 2016-02-09 The General Hospital Corporation Method and apparatus for imaging of vessel segments
US8965487B2 (en) 2004-08-24 2015-02-24 The General Hospital Corporation Process, system and software arrangement for measuring a mechanical strain and elastic properties of a sample
US8208995B2 (en) 2004-08-24 2012-06-26 The General Hospital Corporation Method and apparatus for imaging of vessel segments
USRE43875E1 (en) 2004-09-29 2012-12-25 The General Hospital Corporation System and method for optical coherence imaging
USRE45512E1 (en) 2004-09-29 2015-05-12 The General Hospital Corporation System and method for optical coherence imaging
US7995210B2 (en) 2004-11-24 2011-08-09 The General Hospital Corporation Devices and arrangements for performing coherence range imaging using a common path interferometer
US9326682B2 (en) 2005-04-28 2016-05-03 The General Hospital Corporation Systems, processes and software arrangements for evaluating information associated with an anatomical structure by an optical coherence ranging technique
US8351665B2 (en) 2005-04-28 2013-01-08 The General Hospital Corporation Systems, processes and software arrangements for evaluating information associated with an anatomical structure by an optical coherence ranging technique
US7859679B2 (en) 2005-05-31 2010-12-28 The General Hospital Corporation System, method and arrangement which can use spectral encoding heterodyne interferometry techniques for imaging
US9441948B2 (en) 2005-08-09 2016-09-13 The General Hospital Corporation Apparatus, methods and storage medium for performing polarization-based quadrature demodulation in optical coherence tomography
US9304121B2 (en) 2005-09-29 2016-04-05 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US7843572B2 (en) 2005-09-29 2010-11-30 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US8289522B2 (en) 2005-09-29 2012-10-16 The General Hospital Corporation Arrangements and methods for providing multimodality microscopic imaging of one or more biological structures
US8760663B2 (en) 2005-09-29 2014-06-24 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US8384907B2 (en) 2005-09-29 2013-02-26 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US9513276B2 (en) 2005-09-29 2016-12-06 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US7847949B2 (en) 2005-09-29 2010-12-07 The General Hospital Corporation Method and apparatus for optical imaging via spectral encoding
US8928889B2 (en) 2005-09-29 2015-01-06 The General Hospital Corporation Arrangements and methods for providing multimodality microscopic imaging of one or more biological structures
US7889348B2 (en) 2005-10-14 2011-02-15 The General Hospital Corporation Arrangements and methods for facilitating photoluminescence imaging
US7796270B2 (en) 2006-01-10 2010-09-14 The General Hospital Corporation Systems and methods for generating data based on one or more spectrally-encoded endoscopy techniques
US8818149B2 (en) 2006-01-19 2014-08-26 The General Hospital Corporation Spectrally-encoded endoscopy techniques, apparatus and methods
US8145018B2 (en) 2006-01-19 2012-03-27 The General Hospital Corporation Apparatus for obtaining information for a structure using spectrally-encoded endoscopy techniques and methods for producing one or more optical arrangements
US9516997B2 (en) 2006-01-19 2016-12-13 The General Hospital Corporation Spectrally-encoded endoscopy techniques, apparatus and methods
US9087368B2 (en) 2006-01-19 2015-07-21 The General Hospital Corporation Methods and systems for optical imaging or epithelial luminal organs by beam scanning thereof
US9186066B2 (en) 2006-02-01 2015-11-17 The General Hospital Corporation Apparatus for applying a plurality of electro-magnetic radiations to a sample
US9186067B2 (en) 2006-02-01 2015-11-17 The General Hospital Corporation Apparatus for applying a plurality of electro-magnetic radiations to a sample
US7982879B2 (en) 2006-02-24 2011-07-19 The General Hospital Corporation Methods and systems for performing angle-resolved fourier-domain optical coherence tomography
US7742173B2 (en) 2006-04-05 2010-06-22 The General Hospital Corporation Methods, arrangements and systems for polarization-sensitive optical frequency domain imaging of a sample
US8175685B2 (en) 2006-05-10 2012-05-08 The General Hospital Corporation Process, arrangements and systems for providing frequency domain imaging of a sample
US9364143B2 (en) 2006-05-10 2016-06-14 The General Hospital Corporation Process, arrangements and systems for providing frequency domain imaging of a sample
US7782464B2 (en) 2006-05-12 2010-08-24 The General Hospital Corporation Processes, arrangements and systems for providing a fiber layer thickness map based on optical coherence tomography images
US8246611B2 (en) 2006-06-14 2012-08-21 Candela Corporation Treatment of skin by spatial modulation of thermal heating
US9486285B2 (en) 2006-06-14 2016-11-08 Candela Corporation Treatment of skin by spatial modulation of thermal heating
US7920271B2 (en) 2006-08-25 2011-04-05 The General Hospital Corporation Apparatus and methods for enhancing optical coherence tomography imaging using volumetric filtering techniques
US8838213B2 (en) 2006-10-19 2014-09-16 The General Hospital Corporation Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s)
US7949019B2 (en) 2007-01-19 2011-05-24 The General Hospital Wavelength tuning source based on a rotatable reflector
US9176319B2 (en) 2007-03-23 2015-11-03 The General Hospital Corporation Methods, arrangements and apparatus for utilizing a wavelength-swept laser using angular scanning and dispersion procedures
US8115919B2 (en) 2007-05-04 2012-02-14 The General Hospital Corporation Methods, arrangements and systems for obtaining information associated with a sample using optical microscopy
US9375158B2 (en) 2007-07-31 2016-06-28 The General Hospital Corporation Systems and methods for providing beam scan patterns for high speed doppler optical frequency domain imaging
US8040608B2 (en) 2007-08-31 2011-10-18 The General Hospital Corporation System and method for self-interference fluorescence microscopy, and computer-accessible medium associated therewith
US7933021B2 (en) 2007-10-30 2011-04-26 The General Hospital Corporation System and method for cladding mode detection
US9332942B2 (en) 2008-01-28 2016-05-10 The General Hospital Corporation Systems, processes and computer-accessible medium for providing hybrid flourescence and optical coherence tomography imaging
US8593619B2 (en) 2008-05-07 2013-11-26 The General Hospital Corporation System, method and computer-accessible medium for tracking vessel motion during three-dimensional coronary artery microscopy
US8861910B2 (en) 2008-06-20 2014-10-14 The General Hospital Corporation Fused fiber optic coupler arrangement and method for use thereof
US9254089B2 (en) 2008-07-14 2016-02-09 The General Hospital Corporation Apparatus and methods for facilitating at least partial overlap of dispersed ration on at least one sample
US8937724B2 (en) 2008-12-10 2015-01-20 The General Hospital Corporation Systems and methods for extending imaging depth range of optical coherence tomography through optical sub-sampling
US8097864B2 (en) 2009-01-26 2012-01-17 The General Hospital Corporation System, method and computer-accessible medium for providing wide-field superresolution microscopy
US9178330B2 (en) 2009-02-04 2015-11-03 The General Hospital Corporation Apparatus and method for utilization of a high-speed optical wavelength tuning source
US9351642B2 (en) 2009-03-12 2016-05-31 The General Hospital Corporation Non-contact optical system, computer-accessible medium and method for measurement at least one mechanical property of tissue using coherent speckle technique(s)
US8804126B2 (en) 2010-03-05 2014-08-12 The General Hospital Corporation Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution
US9408539B2 (en) 2010-03-05 2016-08-09 The General Hospital Corporation Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution
US9081148B2 (en) 2010-03-05 2015-07-14 The General Hospital Corporation Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution
US8896838B2 (en) 2010-03-05 2014-11-25 The General Hospital Corporation Systems, methods and computer-accessible medium which provide microscopic images of at least one anatomical structure at a particular resolution
US9069130B2 (en) 2010-05-03 2015-06-30 The General Hospital Corporation Apparatus, method and system for generating optical radiation from biological gain media
US9557154B2 (en) 2010-05-25 2017-01-31 The General Hospital Corporation Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions
US9510758B2 (en) 2010-10-27 2016-12-06 The General Hospital Corporation Apparatus, systems and methods for measuring blood pressure within at least one vessel
US8721077B2 (en) 2011-04-29 2014-05-13 The General Hospital Corporation Systems, methods and computer-readable medium for determining depth-resolved physical and/or optical properties of scattering media by analyzing measured data over a range of depths
US9330092B2 (en) 2011-07-19 2016-05-03 The General Hospital Corporation Systems, methods, apparatus and computer-accessible-medium for providing polarization-mode dispersion compensation in optical coherence tomography
US9341783B2 (en) 2011-10-18 2016-05-17 The General Hospital Corporation Apparatus and methods for producing and/or providing recirculating optical delay(s)
US9415550B2 (en) 2012-08-22 2016-08-16 The General Hospital Corporation System, method, and computer-accessible medium for fabrication miniature endoscope using soft lithography

Also Published As

Publication number Publication date
CN1233454A (en) 1999-11-03
KR100454522B1 (en) 2004-11-03
DE69937850T2 (en) 2008-12-18
JP3229280B2 (en) 2001-11-19
EP0933096A2 (en) 1999-08-04
KR19990067923A (en) 1999-08-25
JPH11267131A (en) 1999-10-05
TW403667B (en) 2000-09-01
SG114454A1 (en) 2005-09-28
HK1021499A1 (en) 2000-06-16
US6165170A (en) 2000-12-26
EP0933096A3 (en) 1999-11-03
DE69937850D1 (en) 2008-02-14
US6447503B1 (en) 2002-09-10
CN1145460C (en) 2004-04-14

Similar Documents

Publication Publication Date Title
EP0933096B1 (en) Laser for dermal ablation
US10299871B2 (en) Automated system and method for hair removal
JP7111693B2 (en) Automatic system and method for hair removal
US6676654B1 (en) Apparatus for tissue treatment and having a monitor for display of tissue features
US20050137584A1 (en) Method and apparatus for providing facial rejuvenation treatments
EP2316373B1 (en) Apparatus for dermatological treatment and fractional skin resurfacing
AU2002227447C1 (en) Method and apparatus for therapeutic EMR treatment of the skin
US20060253176A1 (en) Dermatological treatment device with deflector optic
JP6095013B2 (en) System and method for altering and / or smoothing tissue by laser ablation
AU2002227447A1 (en) Method and apparatus for therapeutic EMR treatment of the skin
WO2019200111A1 (en) Diffractive optics for emr-based tissue treatment
Smithies et al. A computer controlled scanner for the laser treatment of vascular lesions and hyperpigmentation
Neev et al. Thermo-optical skin conditioning: a new method for thermally modifying skin conditions
Butler et al. Treatment of Port-Wine Stains with the 578 NM Light from a Copper Vapour Laser and an Automated Scanning Device

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): DE FR GB NL

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RTI1 Title (correction)

Free format text: LASER FOR DERMAL ABLATION

17P Request for examination filed

Effective date: 20000128

AKX Designation fees paid

Free format text: DE GB IT SE

RBV Designated contracting states (corrected)

Designated state(s): DE FR GB NL

17Q First examination report despatched

Effective date: 20030606

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61N 5/067 20060101AFI20070529BHEP

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE FR GB NL

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69937850

Country of ref document: DE

Date of ref document: 20080214

Kind code of ref document: P

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20081003

REG Reference to a national code

Ref country code: GB

Ref legal event code: 746

Effective date: 20081215

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 18

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 19

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20180119

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20180130

Year of fee payment: 20

Ref country code: DE

Payment date: 20171227

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20180112

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69937850

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MK

Effective date: 20190111

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20190111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20190111